<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?subarticle pcbi.1009480.r001?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS Computational Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-734X</issn>
    <issn pub-type="epub">1553-7358</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8553042</article-id>
    <article-id pub-id-type="pmid">34662338</article-id>
    <article-id pub-id-type="publisher-id">PCOMPBIOL-D-21-00213</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009480</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pulmonology</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Structure</subject>
              <subj-group>
                <subject>Virions</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Replication</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Molecular Biology</subject>
          <subj-group>
            <subject>Molecular Biology Techniques</subject>
            <subj-group>
              <subject>Molecular Biology Assays and Analysis Techniques</subject>
              <subj-group>
                <subject>Focus-Forming Assay</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Molecular Biology Techniques</subject>
          <subj-group>
            <subject>Molecular Biology Assays and Analysis Techniques</subject>
            <subj-group>
              <subject>Focus-Forming Assay</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Approximation Methods</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
              <subj-group>
                <subject>Respiratory Syncytial Virus Infection</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
              <subj-group>
                <subject>Respiratory Syncytial Virus Infection</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pulmonology</subject>
          <subj-group>
            <subject>Respiratory Disorders</subject>
            <subj-group>
              <subject>Respiratory Infections</subject>
              <subj-group>
                <subject>Respiratory Syncytial Virus Infection</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Viral Diseases</subject>
              <subj-group>
                <subject>Respiratory Syncytial Virus Infection</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Infectious Diseases</subject>
            <subj-group>
              <subject>Viral Diseases</subject>
              <subj-group>
                <subject>Influenza</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Biological Cultures</subject>
          <subj-group>
            <subject>Cell Cultures</subject>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Time to revisit the endpoint dilution assay and to replace the TCID<sub>50</sub> as a measure of a virus sample’s infection concentration</article-title>
      <alt-title alt-title-type="running-head">Replacing TCID<sub>50</sub> with Specific INfections (SIN) to quantify a virus sample’s infectivity</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7524-9001</contrib-id>
        <name>
          <surname>Cresta</surname>
          <given-names>Daniel</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="currentaff001" ref-type="author-notes">
          <sup>¤</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3222-9059</contrib-id>
        <name>
          <surname>Warren</surname>
          <given-names>Donald C.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9461-6660</contrib-id>
        <name>
          <surname>Quirouette</surname>
          <given-names>Christian</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2428-1620</contrib-id>
        <name>
          <surname>Smith</surname>
          <given-names>Amanda P.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9600-0472</contrib-id>
        <name>
          <surname>Lane</surname>
          <given-names>Lindey C.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7092-6904</contrib-id>
        <name>
          <surname>Smith</surname>
          <given-names>Amber M.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff003" ref-type="aff">
          <sup>3</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0599-0069</contrib-id>
        <name>
          <surname>Beauchemin</surname>
          <given-names>Catherine A. A.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Resources</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Supervision</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Department of Physics, Ryerson University, Toronto, Ontario, Canada</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Interdisciplinary Theoretical and Mathematical Sciences (iTHEMS) program, RIKEN, Wako-shi, Saitama, Japan</addr-line>
    </aff>
    <aff id="aff003">
      <label>3</label>
      <addr-line>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Regoes</surname>
          <given-names>Roland R.</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>ETH Zurich, SWITZERLAND</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="current-aff" id="currentaff001">
        <label>¤</label>
        <p>Current address: Department of Physics and Astronomy, Western University, London, Ontario, Canada</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>cbeau@ryerson.ca</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>18</day>
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <volume>17</volume>
    <issue>10</issue>
    <elocation-id>e1009480</elocation-id>
    <history>
      <date date-type="received">
        <day>3</day>
        <month>2</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>26</day>
        <month>9</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 Cresta et al</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>Cresta et al</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pcbi.1009480.pdf"/>
    <abstract>
      <p>The endpoint dilution assay’s output, the 50% infectious dose (ID<sub>50</sub>), is calculated using the Reed-Muench or Spearman-Kärber mathematical approximations, which are biased and often miscalculated. We introduce a replacement for the ID<sub>50</sub> that we call Specific INfection (SIN) along with a free and open-source web-application, <bold>midSIN</bold> (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>) to calculate it. <bold>midSIN</bold> computes a virus sample’s SIN concentration using Bayesian inference based on the results of a standard endpoint dilution assay, and requires no changes to current experimental protocols. We analyzed influenza and respiratory syncytial virus samples using <bold>midSIN</bold> and demonstrated that the SIN/mL reliably corresponds to the number of infections a sample will cause per mL. It can therefore be used directly to achieve a desired multiplicity of infection, similarly to how plaque or focus forming units (PFU, FFU) are used. <bold>midSIN</bold>’s estimates are shown to be more accurate and robust than the Reed-Muench and Spearman-Kärber approximations. The impact of endpoint dilution plate design choices (dilution factor, replicates per dilution) on measurement accuracy is also explored. The simplicity of SIN as a measure and the greater accuracy provided by <bold>midSIN</bold> make them an easy and superior replacement for the TCID<sub>50</sub> and other <italic toggle="yes">in vitro</italic> culture ID<sub>50</sub> measures. We hope to see their universal adoption to measure the infectivity of virus samples.</p>
    </abstract>
    <abstract abstract-type="summary">
      <title>Author summary</title>
      <p>The infectivity of a virus sample is measured by the infections it causes. One approach, the endpoint dilution assay, aims to estimate the number of TCID<sub>50</sub> contained in a sample, where one TCID<sub>50</sub> is the dose at which a virus sample is expected to infect a tissue or cell culture 50% of the time, on average. Unfortunately, the commonly used methods to estimate the TCID<sub>50</sub> from the assay’s outcome yield biased approximations that relate poorly to the number of infections the sample will cause. We propose replacing the TCID<sub>50</sub> with a more accurate, robust, and biologically meaningful measurement unit we call Specific INfection (SIN). It corresponds to the number of infections the virus sample will cause, which can be used directly to achieve the desired multiplicity of infection. Computing the SIN from one’s endpoint dilution assay outcome requires no change in experimental procedure, and can be done conveniently via a web-application we developed, called <bold>midSIN</bold>. <bold>midSIN</bold> can be accessed for free on any device (laptop, cellular phone, tablet) from any web browser, without the need to download and install software.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000038</institution-id>
            <institution>Natural Sciences and Engineering Research Council of Canada</institution>
          </institution-wrap>
        </funding-source>
        <award-id>355837-2013</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0599-0069</contrib-id>
          <name>
            <surname>Beauchemin</surname>
            <given-names>Catherine A. A.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003400</institution-id>
            <institution>Ontario Ministry of Research, Innovation and Science</institution>
          </institution-wrap>
        </funding-source>
        <award-id>ER13-09-040</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0599-0069</contrib-id>
          <name>
            <surname>Beauchemin</surname>
            <given-names>Catherine A. A.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award003">
        <funding-source>
          <institution>Interdisciplinary Theoretical and Mathematical Sciences</institution>
        </funding-source>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0599-0069</contrib-id>
          <name>
            <surname>Beauchemin</surname>
            <given-names>Catherine A. A.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award004">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
            <institution>National Institute of Allergy and Infectious Diseases</institution>
          </institution-wrap>
        </funding-source>
        <award-id>AI139088</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2428-1620</contrib-id>
          <name>
            <surname>Smith</surname>
            <given-names>Amanda P.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This work was supported in part by Discovery Grant 355837-2013 (CAAB) from the Natural Sciences and Engineering Research Council of Canada (<ext-link xlink:href="http://www.nserc-crsng.gc.ca" ext-link-type="uri">www.nserc-crsng.gc.ca</ext-link>), Early Researcher Award ER13-09-040 (CAAB) from the Ministry of Research and Innovation of the Government of Ontario (<ext-link xlink:href="http://www.ontario.ca/page/early-researcher-awards" ext-link-type="uri">www.ontario.ca/page/early-researcher-awards</ext-link>), by the Interdisciplinary Theoretical and Mathematical Sciences programme (iTHEMS, ithems.riken.jp) at RIKEN (CAAB), and by R01 AI139088 (AMS, APS, LCL) from the NIH NIAID (<ext-link xlink:href="http://www.niaid.nih.gov" ext-link-type="uri">www.niaid.nih.gov</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="8"/>
      <table-count count="0"/>
      <page-count count="20"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>PLOS Publication Stage</meta-name>
        <meta-value>vor-update-to-uncorrected-proof</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>Publication Update</meta-name>
        <meta-value>2021-10-28</meta-value>
      </custom-meta>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>The authors confirm that all data underlying the findings are fully available without restriction. The code is freely available on GitHub (<ext-link xlink:href="https://github.com/cbeauc/midSIN" ext-link-type="uri">https://github.com/cbeauc/midSIN</ext-link>) and the midSIN tool is available as a web application (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>).</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>The authors confirm that all data underlying the findings are fully available without restriction. The code is freely available on GitHub (<ext-link xlink:href="https://github.com/cbeauc/midSIN" ext-link-type="uri">https://github.com/cbeauc/midSIN</ext-link>) and the midSIN tool is available as a web application (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>).</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Introduction</title>
    <p>The progression of a virus infection <italic toggle="yes">in vivo</italic> or <italic toggle="yes">in vitro</italic>, or the effectiveness of therapeutic interventions in reducing viral loads, are monitored over time through sample collections to measure changes (increases or decreases) in virus concentrations. As such, accurate measurement of the concentration in a sample is critical to study and manage virus infections.</p>
    <p>Methods to count infectious virus are based on counting the infections they cause, rather than the particles themselves. In practice, however, not all infection-competent virions contained in a sample will go on to successfully cause infection. Experimental conditions, cell type used or temperature or acidity of the medium, can alter the rate at which virions, that were infection-competent in the sample, will lose infectivity before they can cause infection and thus be counted. This is why, hereafter, we will refer to the quantity measured by infectivity assays as the <italic toggle="yes">infection concentration</italic> or the number of infections the sample will cause per unit volume, rather than its concentration of infectious virions, which is not a measurable quantity. Two main types of assays are used to quantify the infection concentration within a virus sample: (1) the plaque forming (PFU) or focus forming (FFU) assays; and (2) assays we will collectively refer to as endpoint dilution (ED) assays, which include the 50% tissue culture infectious dose (TCID<sub>50</sub>), or cell culture infectious dose (CCID<sub>50</sub>) or egg infectious dose (EID<sub>50</sub>) assays, etc. Herein, we focus on ED assays. Technically, the plaque and focus forming assays are also endpoint dilution assays because they rely on the counting of plaques or foci (the endpoint) as a function of dilutions. However, herein, we will refer to them as plaque or foci forming assays rather than endpoint dilution assays.</p>
    <p>The ED assay has one major, remediable weakness: its output quantity, the TCID<sub>50</sub> (or CCID<sub>50</sub> or EID<sub>50</sub>), does not directly correspond, or trivially relate, to causing one infected cell. The simplistic calculations, introduced by Spearman-Kärber (SK) [<xref rid="pcbi.1009480.ref001" ref-type="bibr">1</xref>, <xref rid="pcbi.1009480.ref002" ref-type="bibr">2</xref>] and Reed-Muench (RM) [<xref rid="pcbi.1009480.ref003" ref-type="bibr">3</xref>] nearly a century ago, remain the most commonly used methods to quantify a virus sample’s infectivity in units of TCID<sub>50</sub> (or CCID<sub>50</sub> or EID<sub>50</sub>) using the ED assay. Many research groups rely on spreadsheet calculators that are passed down through generations of trainees or found on the internet, and can contain errors (e.g., versions 2 and 3 of the spreadsheet calculator provided by the Lindenbach Lab at Yale University (<ext-link xlink:href="http://lindenbachlab.org/resources.html" ext-link-type="uri">http://lindenbachlab.org/resources.html</ext-link>), which have since been removed). Theoretically, a dose of 1 TCID<sub>50</sub> is expected to cause −1/ln(50%) = 1.44 infections [<xref rid="pcbi.1009480.ref004" ref-type="bibr">4</xref>]. However, the approximation used by the RM and SK methods introduces an often overlooked bias where 1 TCID<sub>50</sub> ≈ 1.781 infections where 1.781 = e<sup><italic toggle="yes">γ</italic></sup> and <italic toggle="yes">γ</italic> = 0.5772 is the Euler-Mascheroni constant [<xref rid="pcbi.1009480.ref005" ref-type="bibr">5</xref>, <xref rid="pcbi.1009480.ref006" ref-type="bibr">6</xref>]. This makes it problematic to experimentally achieve the desired multiplicity of infection when inoculating from a sample quantified via the RM or SK methods. Many have proposed replacements for the RM and SK calculations based on logit or probit transforms of the data [<xref rid="pcbi.1009480.ref004" ref-type="bibr">4</xref>, <xref rid="pcbi.1009480.ref006" ref-type="bibr">6</xref>, <xref rid="pcbi.1009480.ref007" ref-type="bibr">7</xref>] or on statistical analysis of the ED assay output [<xref rid="pcbi.1009480.ref007" ref-type="bibr">7</xref>, <xref rid="pcbi.1009480.ref008" ref-type="bibr">8</xref>] with some implemented as website applications [<xref rid="pcbi.1009480.ref009" ref-type="bibr">9</xref>, <xref rid="pcbi.1009480.ref010" ref-type="bibr">10</xref>]. Sadly, none of these improvements were widely adopted to improve estimates of the TCID<sub>50</sub>, possibly due to a lack of visibility of these publications, or the lack of widespread awareness of the limitations of the RM and SK methods. None proposed replacing the TCID<sub>50</sub> measurement unit, with a more meaningful measure.</p>
    <p>The work herein proposes to:</p>
    <list list-type="order">
      <list-item>
        <p>Encourage the use of the ED assay (e.g., TCID<sub>50</sub> assay), but replace its output, the TCID<sub>50</sub>/mL (or CCID<sub>50</sub>/mL, EID<sub>50</sub>/mL, etc.), with a new quantity in units of <bold><underline>S</underline></bold>pecific <bold><underline>IN</underline></bold>fections or SIN/mL which corresponds to the number of infections the sample will cause per mL. The word <italic toggle="yes">specific</italic> highlights the fact that the infectivity of a sample is specific to the particulars of the experimental conditions (temperature, medium, cell type, incubation time, etc.).</p>
      </list-item>
      <list-item>
        <p>Replace the Reed-Muench and Spearman-Kärber approximations with a computer software, <bold>midSIN</bold> (<bold><underline>m</underline></bold>easure of <bold><underline>i</underline></bold>nfectious <bold><underline>d</underline></bold>ose in <bold><underline>SIN</underline></bold>), that relies on Bayesian inference to measure the SIN/mL of a virus sample. To avoid calculation errors and make the new method widely accessible, <bold>midSIN</bold> is maintained and distributed as free, open-source software on GitHub (<ext-link xlink:href="https://github.com/cbeauc/midSIN" ext-link-type="uri">https://github.com/cbeauc/midSIN</ext-link>) for user installation, but also via a free-to-use website application (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>) with an intuitive user interface.</p>
      </list-item>
    </list>
    <p>Here, we present examples of <bold>midSIN</bold> being used to analyze influenza and respiratory syncytial virus samples. We demonstrate that <bold>midSIN</bold>’s output, SIN/mL, is an accurate estimate of the number of infections the sample will cause per unit volume. We show how the accuracy of the SIN concentration estimate can be controlled by experimental choice of plate layout, including the dilution factor, and the number of replicates per dilution. We compare <bold>midSIN</bold>’s performance to that of the RM and SK methods, and demonstrate how the latter estimators are inaccurate under various circumstances, underlining the need to adopt <bold>midSIN</bold> to quantify virus samples via the ED assay.</p>
  </sec>
  <sec sec-type="results" id="sec002">
    <title>Results</title>
    <sec id="sec003">
      <title>Key features of midSIN’s output</title>
      <p>Let us consider a fictitious ED experiment, with 11 dilutions and 8 replicate wells per dilutions, in which the minimum sample dilution, <inline-formula id="pcbi.1009480.e001"><alternatives><graphic xlink:href="pcbi.1009480.e001.jpg" id="pcbi.1009480.e001g" position="anchor"/><mml:math id="M1" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>100</mml:mn><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, is serially diluted by a factor of 10<sup>−0.5</sup> ≈ 0.32 (<inline-formula id="pcbi.1009480.e002"><alternatives><graphic xlink:href="pcbi.1009480.e002.jpg" id="pcbi.1009480.e002g" position="anchor"/><mml:math id="M2" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pcbi.1009480.e003"><alternatives><graphic xlink:href="pcbi.1009480.e003.jpg" id="pcbi.1009480.e003g" position="anchor"/><mml:math id="M3" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, …, <inline-formula id="pcbi.1009480.e004"><alternatives><graphic xlink:href="pcbi.1009480.e004.jpg" id="pcbi.1009480.e004g" position="anchor"/><mml:math id="M4" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>), and the total volume of inoculum (diluted virus sample + dilutant) placed in each well is <italic toggle="yes">V</italic><sub>inoc</sub> = 0.1 mL. Now, consider that a virus sample is measured using this ED experiment and one observes (8,8,8,8,8,7,7,5,2,0,0) infected wells out of 8 replicates at each of the 11 dilutions, as illustrated in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1A</xref>.</p>
      <fig position="float" id="pcbi.1009480.g001">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>Visual representation of midSIN’s output for the example ED plate.</title>
          <p>A: Illustration of the example ED plate where <inline-formula id="pcbi.1009480.e005"><alternatives><graphic xlink:href="pcbi.1009480.e005" id="pcbi.1009480.e005g" position="anchor"/><mml:math id="M5" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula> are the chosen serial dilutions of the sample. For the example described in the text, <inline-formula id="pcbi.1009480.e006"><alternatives><graphic xlink:href="pcbi.1009480.e006" id="pcbi.1009480.e006g" position="anchor"/><mml:math id="M6" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pcbi.1009480.e007"><alternatives><graphic xlink:href="pcbi.1009480.e007" id="pcbi.1009480.e007g" position="anchor"/><mml:math id="M7" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, …, <inline-formula id="pcbi.1009480.e008"><alternatives><graphic xlink:href="pcbi.1009480.e008" id="pcbi.1009480.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, with 8 replicates per dilution. The number of infected wells (# inf) is indicated at the bottom of each dilution column. B: The <bold>midSIN</bold>-estimated posterior distribution of the log<sub>10</sub> infection concentration, log<sub>10</sub>(SIN/mL), for the example ED experiment. The vertical lines correspond to log<sub>10</sub>(SIN/mL), based on the most likely value (mode) of <bold>midSIN</bold>’s posterior distribution (solid blue), or computed from the RM (solid orange) and SK (dashed green) approximations of the log<sub>10</sub>(TCID<sub>50</sub>) (see <xref rid="sec008" ref-type="sec">Methods</xref>). The <italic toggle="yes">x</italic>-value of the white and light grey region on either sides of the mode indicate the edges of the 68% and 95% credible interval (CI), respectively. The <bold>midSIN</bold>-estimated log<sub>10</sub>(SIN/mL) mode ± 68% [±95%] CI are indicated numerically above the graph. C: The number of infected wells (black circles) out of the 8 replicates, as a function of the 11 serial dilutions of the example ED plate, from the least (leftmost) to the most (rightmost) diluted. For example, <italic toggle="yes">x</italic> = 3.0 corresponds to a sample dilution of 10<sup>−3</sup> or 1/1,000. The average (expected) number of infected wells, as a function of sample dilution, is shown for the most likely value of log<sub>10</sub>(SIN/mL) (blue curve) or its 68% and 95% CI (inner and outer edge of the grey bands, respectively). The sample dilution (<italic toggle="yes">x</italic>-value) at which the blue curve crosses the horizontal dotted line (50% infected wells) corresponds to a concentration of 1 TCID<sub>50</sub> per ED well volume. The vertical lines indicate the sample dilution that yields a concentration of 1 TCID<sub>50</sub> according to the RM and SK approximations.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g001" position="float"/>
      </fig>
      <p><bold>midSIN</bold> provides a graphical output of its results, shown in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1B and 1C</xref> for this example. Note how the posterior distribution for log<sub>10</sub>(SIN/mL) (<xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1B</xref>) is approximately a normal distribution. This is why log<sub>10</sub> of the infection concentration should be used and reported, rather than the concentration itself. <bold>midSIN</bold> also graphically compares the number of infected wells observed experimentally (<xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1C</xref>, black dots) against the theoretically expected values (blue curve and grey CI bands). This graphical representation makes it easy to identify issues with the data entered or with the experiment itself.</p>
      <p>Importantly, <bold>midSIN</bold> provides a more useful quantity to the user than the TCID<sub>50</sub>: an estimate of the concentration of infections the sample will cause, SIN/mL. For this example, the concentration is 10<sup>6.2±0.1</sup> SIN/mL, where 6.2 is the mode (most likely value) of log<sub>10</sub>(SIN/mL), and ±0.1 is its 68% credible interval (CI). The SIN/mL corresponds to the number of infections that will be caused per mL of the sample, which can be directly used to determine the sample dilution required to obtain a desired multiplicity of infection (MOI).</p>
      <p>In a laboratory setting, ED experiments can be performed in batches, such as to quantify the infectious concentration in samples collected at several time points over the course of a cell culture infection. For such applications, <bold>midSIN</bold> provides a comma separated value (csv) template file readily editable in a spreadsheet program, to collect and submit the results for batch processing. Details on the format of the template file are available on <bold>midSIN</bold>’s website (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>). <xref rid="pcbi.1009480.g002" ref-type="fig">Fig 2</xref> illustrates the output for a subset of measurements for <italic toggle="yes">in vitro</italic> infection with the respiratory syncytial virus (RSV). Each sample was measured twice, and <bold>midSIN</bold>’s estimates are in good agreement with one another (within 95% CI).</p>
      <fig position="float" id="pcbi.1009480.g002">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Quantification of RSV sampled from <italic toggle="yes">in vitro</italic> infections.</title>
          <p>Each row corresponds to a different experiment (mock-yield [my] or single-cycle [sc]) and sampling time point (e.g., 8 h, 36 h), and each sample was measured in duplicate (rep1, rep2). These data were collected from <italic toggle="yes">in vitro</italic> infections with the RSV A Long strain, and were previously reported in [<xref rid="pcbi.1009480.ref011" ref-type="bibr">11</xref>]. The ED measurement experiment were conducted using a plate layout of 11 dilutions, with 8 replicates per dilution, an inoculum volume of <italic toggle="yes">V</italic><sub>inoc</sub> = 0.1 mL, serial dilutions from <inline-formula id="pcbi.1009480.e009"><alternatives><graphic xlink:href="pcbi.1009480.e009" id="pcbi.1009480.e009g" position="anchor"/><mml:math id="M9" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> to <inline-formula id="pcbi.1009480.e010"><alternatives><graphic xlink:href="pcbi.1009480.e010" id="pcbi.1009480.e010g" position="anchor"/><mml:math id="M10" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, separated by a dilution factor of 10<sup>−0.5</sup>.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g002" position="float"/>
      </fig>
      <p>The <italic toggle="yes">y</italic>-axis in the left graph panels of <bold>midSIN</bold>’s graphical output is the non-normalized scale of the posterior distribution for log<sub>10</sub>(SIN/mL), which ranges between 10<sup>−7</sup> and 10<sup>−2</sup>. The scale loosely relates to the likelihood of observing a particular ED experimental outcome (see <xref rid="sec008" ref-type="sec">Methods</xref>). Unlikely ED outcomes appear as large departures of the observed number of infected wells (right panels, black dots) from what is theoretically expected (right panels, curve). It is interesting that the uncertainty (CI) of <bold>midSIN</bold>’s estimated log<sub>10</sub>(SIN/mL) appears to be independent of how much the ED outcome deviates from theoretical expectations. That is, the accuracy of <bold>midSIN</bold> is not strongly affected even when it is provided more unlikely, noisy experimental data. This robustness is explored further below.</p>
    </sec>
    <sec id="sec004">
      <title>Comparing SIN to TCID<sub>50</sub> and PFU virus sample concentrations</title>
      <p>The <bold>midSIN</bold> calculator provides an estimate of the number of infections that will be caused per mL of a virus sample (SIN/mL). In principle, a plaque assay also measures the number of infections a sample will cause, with each infection expected to develop into a plaque. If a plaque assay is performed under experimental conditions and protocols as similar as possible to those of the ED assay (i.e., using the same cells, medium, period of incubation, rinsing method, etc.), <bold>midSIN</bold>’s SIN/mL estimate is expected to be comparable, in theory, to the number of PFU/mL observed in the plaque assay. In practice, however, the plaque assay likely provides a biased estimate of the true concentration of infections in a sample due to various experimental limitations (e.g., distinguishing between two merged plaque and a larger one, or between small plaques and staining artifacts). To evaluate <bold>midSIN</bold>’s performance compared to existing methods, the infection concentration in two influenza A (H1N1) virus strain samples were measured via both plaque and ED assays, and their concentration in units of PFU, TCID<sub>50</sub>, and SIN were compared (<xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3</xref>). Details regarding the samples, and how the plaque and ED assays were performed are provided in <xref rid="sec008" ref-type="sec">Methods</xref>.</p>
      <fig position="float" id="pcbi.1009480.g003">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Comparing SIN to TCID<sub>50</sub> and PFU for influenza A virus samples.</title>
          <p>A,B: The infection concentration in two influenza A (H1N1) virus strain samples was measured via both an ED assay and a plaque assay (x, PFU). The ED assay was quantified in log<sub>10</sub>(TCID<sub>50</sub>) using the RM (square) or SK (triangle) methods, or in log<sub>10</sub>(SIN) using <bold>midSIN</bold> (circle with 68%,95% CI). Each of the 2 strain samples was measured over 2 separate experiments (Exp. #1, #2), performed each time by 2 different researchers (Researcher A or B), with 5 biological replicates each. The grey bars indicate the range of log<sub>10</sub>(SIN) values across the 5 replicates. The RM, SK, and SIN measures were estimated for each replicate based on the same ED plate. The experimental details are provided in <xref rid="sec008" ref-type="sec">Methods</xref>. C,D: The log<sub>10</sub> of the ratio between either the TCID<sub>50</sub> via the RM or SK method or the PFU, over the SIN via <bold>midSIN</bold>. The ratios were computed for each replicate (5 × 5 replicates), per experiment, per researcher (25 replicates × 2 researchers × 2 experiments = 100 ratios) shown as individual symbols (dots) for each method (RM, SK, PFU). The mean and 68% CI of the 100 ratios are indicated numerically and as black circles with error bars. The <italic toggle="yes">p</italic>-value indicates whether the ratios are statistically different from unity.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g003" position="float"/>
      </fig>
      <p>The TCID<sub>50</sub> concentrations estimated via the RM and SK methods are ∼1.5–1.7 times larger (<xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3C and 3D</xref>) than the SIN concentration, and the set of ratios are statistically inconsistent with the assumption of equality (<italic toggle="yes">p</italic>-value: 0.01–0.03). Theoretically, 1 TCID<sub>50</sub> is expected to cause 1.44 infections (= 1/ln(2)) [<xref rid="pcbi.1009480.ref004" ref-type="bibr">4</xref>]. However, the RM or SK approximations are known to introduce a bias such that 1 TCID<sub>50</sub> estimated by these methods is expected to cause 1.781 infections (= e<sup><italic toggle="yes">γ</italic></sup> where <italic toggle="yes">γ</italic> = 0.5772 is the Euler-Mascheroni constant) [<xref rid="pcbi.1009480.ref005" ref-type="bibr">5</xref>, <xref rid="pcbi.1009480.ref006" ref-type="bibr">6</xref>]. Using the RM, SK, and SIN measurements presented in <xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3A and 3B</xref>, we confirmed (the mean log<sub>10</sub>(ratio) was re-computed for ratio = (RM/1.781)/SIN and (SK/1.781)/SIN, and found to be 0.85–0.93, which is statistically consistent (<italic toggle="yes">p</italic>-value: 0.1–0.3) with the assumption of equality, i.e., ratio = 10<sup>0</sup> = 1.) that 1.781 SIN ≈ 1 TCID<sub>50</sub> when the latter is estimated via the RM or SK approximations, as expected theoretically if SIN is indeed measuring the infection concentration in a sample.</p>
      <p>Similarly, the ratio of the PFU concentration determined via the plaque assay and the SIN concentrations estimated by <bold>midSIN</bold> is ∼0.89–0.93, which is statistically consistent with the assumption of equality (<italic toggle="yes">p</italic>-value: 0.2–0.5). These results confirm the theoretical expectation that 1 PFU ≈ 1 SIN when the plaque and ED assays are performed in the same manner, as was the case here. This provides further support, via two independent assays, that the SIN concentration estimated by <bold>midSIN</bold> from the ED assay is a robust measure of the infection concentration of a virus sample.</p>
    </sec>
    <sec id="sec005">
      <title>Comparing midSIN’s performance to that of the RM and SK methods</title>
      <p>The RM and SK methods rely on the number of infected wells decreasing as dilution increases. Their estimates are affected when the number of infected wells remains unchanged or even increases as dilution increases, which statistics and experimental data herein (<xref rid="pcbi.1009480.g002" ref-type="fig">Fig 2</xref>) tell us can reasonably occur experimentally. The RM and SK methods also mostly require that at the lowest and highest sample dilutions, all wells be infected and uninfected, respectively. <xref rid="pcbi.1009480.g004" ref-type="fig">Fig 4</xref> provides a graphical representation of how the RM and SK methods estimate the TCID<sub>50</sub> concentration from an ED assay. Simply stated, the RM and SK methods use geometric arguments to estimate the sample dilution at which 50% of wells would be infected. While they are sometimes accurate (<xref rid="pcbi.1009480.g004" ref-type="fig">Fig 4A and 4B</xref>), their simplicity often leads to biased estimates (<xref rid="pcbi.1009480.g004" ref-type="fig">Fig 4C and 4D</xref>).</p>
      <fig position="float" id="pcbi.1009480.g004">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>Visualizing TCID<sub>50</sub> estimation by the RM and SK methods.</title>
          <p>A,C: The RM method first smooths the data by taking the cumulative sum of the number of infected wells from the highest to the lowest dilution, and that of uninfected wells from the lowest to the highest dilution (grey dashed curve). It then identifies the dilution (vertical solid orange line) corresponding to the smooth curve’s 50% crossing point (4/8 wells, horizontal grey line) based on the highest dilution with &gt; 50% wells infected, and the lowest dilution with &lt; 50% wells infected. B,D: The SK method identifies the dilution (vertical dashed green line) such that the area under the curve to its right (pale red) would exactly fill the area over the curve to its left (pale blue). The agreement between the true TCID<sub>50</sub> (blue plus) and the RM and SK estimates is good for the symmetric ED plate outcome in (A,B), but poor for the more irregular outcome in (C,D).</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g004" position="float"/>
      </fig>
      <p>In contrast, <bold>midSIN</bold> is robust to these issues. <xref rid="pcbi.1009480.g005" ref-type="fig">Fig 5</xref> demonstrates how <bold>midSIN</bold> can provide an estimate for the log<sub>10</sub>(SIN/mL) in a sample using the number of infected wells at a single dilution, as long as at least one well is uninfected if all others are infected or vice-versa. This is because <bold>midSIN</bold> relies on Bayesian inference, i.e., when more than one column is available, it uses information from each column successively to revise and improve its estimate. This allows <bold>midSIN</bold> to correct for even large deviations from theoretical expectations, and thus improves its accuracy.</p>
      <fig position="float" id="pcbi.1009480.g005">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g005</object-id>
        <label>Fig 5</label>
        <caption>
          <title>midSIN’s estimate of a sample’s infection concentration based on a single dilution.</title>
          <p>Simulated example of an ED plate with an inoculation volume of <italic toggle="yes">V</italic><sub>inoc</sub> = 0.1 mL. Instead of serial dilutions, a single dilution (<inline-formula id="pcbi.1009480.e011"><alternatives><graphic xlink:href="pcbi.1009480.e011" id="pcbi.1009480.e011g" position="anchor"/><mml:math id="M11" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>) is used, and either 1, 2 or 3 well(s) out of the 4 replicate wells are infected. As the fraction of infected wells increases, the uncertainty on the estimate (68% and 95% CIs) decreases, and the posterior distribution becomes more symmetric (Normal-like). Other features are as explained in the caption of <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1</xref>. The RM and SK methods cannot provide an estimate for these outcomes.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g005" position="float"/>
      </fig>
      <p><xref rid="pcbi.1009480.g006" ref-type="fig">Fig 6</xref> illustrates how well the <bold>midSIN</bold>, RM, and SK methods recover a known input sample concentration in simulated ED experiments, based on a plate layout consisting of 11 dilutions (<inline-formula id="pcbi.1009480.e012"><alternatives><graphic xlink:href="pcbi.1009480.e012.jpg" id="pcbi.1009480.e012g" position="anchor"/><mml:math id="M12" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> to <inline-formula id="pcbi.1009480.e013"><alternatives><graphic xlink:href="pcbi.1009480.e013.jpg" id="pcbi.1009480.e013g" position="anchor"/><mml:math id="M13" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>), a dilution factor of 1/4, and 8 replicates per dilutions. The infection concentration estimated by <bold>midSIN</bold> is in excellent agreement with the input concentration. For the RM and SK methods, which estimate the log<sub>10</sub>(TCID<sub>50</sub>/mL) rather than the log<sub>10</sub>(SIN/mL), the agreement is generally poor due to the bias they introduce. Furthermore, the RM and SK predictions are more variable (wavy pattern), and lose accuracy dramatically as the sample concentration approaches the limits of detection (the 2 ends) which, for the example plate layout simulated here, is around 10<sup>3</sup> SIN/mL and 10<sup>9</sup> SIN/mL. Interestingly, the basic calculations behind the RM and SK methods constrain the set of values they can return (sparsely populated grey histograms), compared to the more continuous range returned by <bold>midSIN</bold>, which contributes to its increased accuracy.</p>
      <fig position="float" id="pcbi.1009480.g006">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g006</object-id>
        <label>Fig 6</label>
        <caption>
          <title>Comparing known input to estimated output concentrations.</title>
          <p>For each input concentration between 10<sup>2.2</sup> and 10<sup>9.4</sup>, one million random ED experiment outcomes (# of positive wells in each dilution column) were generated. For each ED outcome, either A: <bold>midSIN</bold> was used to determine the most likely log<sub>10</sub>(SIN/mL); or the B: RM or C: SK method was used to estimate the log<sub>10</sub>(TCID<sub>50</sub>/mL). Vertically stacked grey bands at each input concentration are sideways histograms, proportional to the number of ED outcomes that yield a given <italic toggle="yes">y</italic>-axis value. The black curves join the median (thick), 68<sup>th</sup> (thin) and 95<sup>th</sup> (dashed) percentile of the histograms, determined at (but not between) each input concentration. A plate layout of 11 dilutions, with 8 replicates per dilution, an inoculum volume of <italic toggle="yes">V</italic><sub>inoc</sub> = 0.1 mL, serial dilutions from <inline-formula id="pcbi.1009480.e014"><alternatives><graphic xlink:href="pcbi.1009480.e014" id="pcbi.1009480.e014g" position="anchor"/><mml:math id="M14" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> to <inline-formula id="pcbi.1009480.e015"><alternatives><graphic xlink:href="pcbi.1009480.e015" id="pcbi.1009480.e015g" position="anchor"/><mml:math id="M15" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, separated by a dilution factor of 10<sup>−0.6</sup> ≈ 1/4 were used in the simulated ED experiments.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g006" position="float"/>
      </fig>
    </sec>
    <sec id="sec006">
      <title>Estimate accuracy as a function of plate layout</title>
      <p>In <xref rid="pcbi.1009480.g002" ref-type="fig">Fig 2</xref>, we observed that even for large discrepancies between the expected (right panels, blue curve) and observed (right panels, black dots) ED assay outcome, the uncertainty (CI) of <bold>midSIN</bold>’s estimate remains relatively unchanged. This apparent robustness is because the uncertainty is primarily determined by the experimental design, namely the change in dilution between columns (dilution factor) and the number of replicate wells per dilution. <xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7</xref> explores the impact of varying either only the dilution factor, or only the number of replicates at each dilution, or varying one at the expense of the other by using a fixed number of wells (96 wells). When using <bold>midSIN</bold>, smaller changes in dilution (e.g., going from a dilution factor of 2.2/100 to 61/100) or more replicates per dilution (4 to 24) each improves the measure’s accuracy (narrower CIs) by comparable amounts, but only when the total number of wells is allowed to increase to accommodate the change. When the total number of wells used is fixed, changing one at the expense of the other leaves the accuracy (CI) unchanged. This is somewhat also true for the log<sub>10</sub>(TCID<sub>50</sub>) output concentration estimated by the RM and SK methods. However, at the smallest dilution factors (10/100 and 2.2/100), the bias introduced by the RM and SK methods becomes even larger and more unpredictable. For the input concentration considered in <xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7</xref> (10<sup>5</sup> SIN/mL), the dilution at which 50% of wells are infected is near the middle dilution. For sample concentrations such that 50% infected wells occur near or at the lowest or highest dilution chosen, the effect is even more significant.</p>
      <fig position="float" id="pcbi.1009480.g007">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g007</object-id>
        <label>Fig 7</label>
        <caption>
          <title>Comparing the effect of the dilution factor and number of replicates per dilution.</title>
          <p>The effect of either A,D,G: decreasing the change in dilution (from a dilution factor of 2.2/100 to 61/100) while keeping 8 replicates per dilution; or B,E,H: increasing the number of replicates per dilutions (4 to 24) while keeping a fixed dilution factor (≈ 35/100); or C,F,I: increasing the dilution factor while decreasing the number of replicates, keeping a fixed number of 96 wells used in total to titer one virus sample. Different rows represent the ratio of the estimated output concentration using (A–C) <bold>midSIN</bold> in SIN/mL, (D–F) RM or (G–I) SK in TCID<sub>50</sub>/mL, and the input concentration. In all cases (A–I), the input concentration was 10<sup>5</sup> SIN/mL, and as the dilution factor was varied, the highest and lowest dilutions in the simulated ED plate were held fixed to <inline-formula id="pcbi.1009480.e016"><alternatives><graphic xlink:href="pcbi.1009480.e016" id="pcbi.1009480.e016g" position="anchor"/><mml:math id="M16" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pcbi.1009480.e017"><alternatives><graphic xlink:href="pcbi.1009480.e017" id="pcbi.1009480.e017g" position="anchor"/><mml:math id="M17" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mtext>last</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, respectively, by changing the total # of dilutions performed (simulated). Everything else is generated, computed, and represented visually as described in the caption of <xref rid="pcbi.1009480.g006" ref-type="fig">Fig 6</xref>.</p>
        </caption>
        <graphic xlink:href="pcbi.1009480.g007" position="float"/>
      </fig>
      <p><xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7</xref> also demonstrates that varying the dilution by smaller increments (e.g., a dilution factor of 61/100 rather than 10/100) provides greater granularity (uniqueness) of ED plate outcomes, and thus, greater accuracy of the log<sub>10</sub> infection concentration estimates. Here, a distinct plate outcome means a distinct number of infected wells at each dilution, with no distinction as to exactly which of the replicate wells (e.g., the second versus the fourth) is infected at each dilution. An ED plate with serial dilutions ranging over 6 orders of magnitude (e.g., 10<sup>−2</sup> to 10<sup>−7</sup>), with 4 different dilutions and 24 replicates/dilution (i.e., dilution factor of 2.2/100) provides ∼10<sup>6</sup> ([24 + 1]<sup>4</sup>) possible, distinct ED plate outcomes (<xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7C, 7F and 7I</xref>, leftmost histogram). In contrast, a plate with the same serial dilution range, but with 24 different dilutions and 4 replicates/dilution (i.e., dilution factor of 61/100) yields ∼10<sup>17</sup> ([4 + 1]<sup>24</sup>) distinct outcomes (<xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7C, 7F and 7I</xref>, rightmost histogram). More generally, [reps + 1]<sup>dils</sup> is the number of distinct plate outcomes for a chosen number of dilutions (dils) and replicates (reps). Having fewer possible plate outcomes means that a larger range of concentrations would share the same most-likely ED plate outcome, yet each plate outcome only maps to one (the most likely) concentration estimate. This means that with fewer dilutions, the concentration estimate is forced to take on the nearest possible value it can take (<xref rid="pcbi.1009480.g007" ref-type="fig">Fig 7</xref>, the next closest grey band in the stack), and the accuracy of the concentration estimate is therefore reduced. So although having a greater number of dilutions is more labour intensive, it should be preferred over having a greater number of replicates per dilution.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec007">
    <title>Discussion</title>
    <p>We have introduced a new calculator tool called <bold>midSIN</bold> to replace the Reed-Muench (RM) and Spearman-Kärber (SK) calculations to quantify the infectivity of a virus sample based on an endpoint dilution (ED) assay. Rather than estimating the TCID<sub>50</sub> of a virus sample, <bold>midSIN</bold> calculates the number of infections the sample will cause, reported in units of specific infections (SIN). It does so without requiring any changes to current ED assay protocols, and can be accessed for free via an open-source web-application (<ext-link xlink:href="https://midsin.physics.ryerson.ca" ext-link-type="uri">https://midsin.physics.ryerson.ca</ext-link>). Importantly, because the SIN of a virus sample corresponds to the number of infections it will cause, it can be used directly to determine what dilution of the sample will achieve the desired multiplicity of infection (MOI).</p>
    <p>Using a combination of <italic toggle="yes">in vitro</italic> and simulated experimental data, we demonstrated that <bold>midSIN</bold> provides more accurate and robust estimates than the biased RM and SK approximations. We confirmed that the RM and SK approximations overestimate the TCID<sub>50</sub> by 23.5%, such that 1 TCID<sub>50</sub> estimated by these methods will cause 1.781 rather than 1.44 infections [<xref rid="pcbi.1009480.ref005" ref-type="bibr">5</xref>, <xref rid="pcbi.1009480.ref006" ref-type="bibr">6</xref>]. While, in theory, the intended MOI can be obtained by multiplying the TCID<sub>50</sub> by 0.7 (or rather ln(2) = 0.693), one should instead multiply by 0.561 to account for the overestimation by RM and SK. Even when accounting for the overestimation, we showed that these methods perform particularly poorly when too few replicate wells per dilutions are used or when the change in dilution is large between successive serial dilutions. The two methods perform especially poorly when quantifying samples whose infection concentration approaches, but is still well within, the detection limit of the ED assay. In such cases, the bias introduced by these methods becomes even larger and more significant. For example, if the minimum and maximum dilutions of an ED plate are 10<sup>−2</sup> and 10<sup>−8</sup>, virus samples with a concentration less than 10<sup>2.2</sup> SIN or greater than 10<sup>7.6</sup> SIN per inoculated well volume (typically 0.1 mL), will see their concentration estimated with an even larger bias by the RM and SK methods.</p>
    <p>Using <bold>midSIN</bold> to measure the infectivity of a virus sample based on an ED assay does not require any change to ED experimental protocols and methods currently in use in one’s laboratory (e.g., dilution factor, replicate per dilution, minimum dilution). Indeed, we demonstrated that <bold>midSIN</bold> can estimate a virus sample’s SIN concentration based on even just a single dilution, as long as replicate wells at that dilution are not all infected or all uninfected. For a given number of ED wells used to titrate the sample and fixed minimum and maximum dilutions (ED detection range), we showed that having smaller changes between dilutions should be favoured over more replicates at each dilution. For example, using 11 dilutions, with a 4-fold dilution factor between dilutions and 8 replicate wells per dilution uses up 88 wells, leaving 8 wells of a 96-well plate for controls. This ED plate design, analyzed using <bold>midSIN</bold>, accurately measures virus sample concentrations ranging over ∼6 orders of magnitude (e.g., [10<sup>1</sup>–10<sup>7</sup>] SIN/mL, or [10<sup>6</sup>–10<sup>12</sup>] SIN/mL, etc.) with an accuracy of ∼1.6-fold (×10<sup>±0.2</sup>, 95% CI). In comparison, using 7 dilutions, with a 10-fold dilution factor, and 4 replicates (which uses 28 rather than 88 wells) would also span 6 orders of magnitude, but with an accuracy of ∼3.2-fold (×10<sup>±0.5</sup>, 95% CI). To put these 2 accuracies in perspective: 1 mL of a sample measured to contain 10 SIN/mL, is expected to yield either 6–16 or 3–31 infections 95% of the time, given an accuracy of either ×10<sup>±0.2</sup> or ×10<sup>±0.5</sup> SIN/mL, respectively. Such an important decrease in accuracy means a reduced ability to detect experimental changes as statistically significant, with the ×10<sup>±0.5</sup> accuracy requiring a &gt;10-fold change for statistical significance. Failing to identify a change as statistically significant as part of a study is far more costly than using more wells for each sample to increase measurement accuracy, and thus the statistical power of the study.</p>
    <p>The <bold>midSIN</bold>-estimated SIN obtained from an ED assay was also compared to the PFU from a plaque assay for a set of influenza A virus samples. When the plaque and ED assays are performed as identically as possible (cell type, incubation time, etc.), as was the case here, 1 SIN ≈ 1 PFU. This demonstrates that indeed <bold>midSIN</bold>’s SIN is a measure of the number of infections a virus sample will cause. However, the plaque and focus forming assays have experimental limitations (time required, sensitivity of target cells to overlay, limited to viruses that cause CPE, subjectivity in counting plaques/foci, etc.) that cause many researchers to titrate virus using ED assays. Indeed <bold>midSIN</bold>’s SIN is a measure of the number of infections a virus sample will cause, and estimating the SIN concentration of a virus sample using data from ED assays is accessible, accurate, and predictive.</p>
    <p>The work herein focused on the virus sample infectivity estimated from an unmodified ED assay. In principle, further improvements in accuracy could be achieved through the use of machine-automated scoring of infected wells using fluorescence intensity or colorimetry. Plate readers can be quite expensive, as are the consumable compounds they require, such as fluorescent antibodies, or antibodies loaded with compounds that can precipitate in the presence of another (colorimeter). In contrast, staining with crystal violet, trypan blue, etc. is an inexpensive and efficient way to identify the widespread cellular pathogenic effect of infection by a lytic virus, as are red blood cells to identify the presence of notable virus concentration in the supernatant of a well infected with a hemagglutination-capable virus. Since the aim of the ED assay is merely to establish whether or not infection occurred, the scoring of a well as having been infected or not, even when done visually, is likely less ambiguous. Therefore, in future work, it would be interesting to compare human- vs machine-scoring of wells to evaluate this step’s contribution to the accuracy of the measure obtained.</p>
    <p>Beyond the work presented herein, the development of <bold>midSIN</bold> will continue online as we implement new features and inputs for integration with various colorimetric and fluorescence instruments. The ease of use of <bold>midSIN</bold> and the greater usefulness and relevance of SIN as a measure of a virus sample’s infectivity make them far superior to the TCID<sub>50</sub>, and other ID<sub>50</sub> measures. We hope to see them adopted widely.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec008">
    <title>Methods</title>
    <sec id="sec009">
      <title>The mathematics of the dose-response assay</title>
      <sec id="sec010">
        <title>Considering a single well</title>
        <p>Consider a virus sample of volume <italic toggle="yes">V</italic><sub>sample</sub> which contains an unknown concentration of infectious virions, <italic toggle="yes">C</italic><sub>inf</sub>, which we aim to determine. Drawing a small volume, <italic toggle="yes">V</italic><sub>inoc</sub> &lt; <italic toggle="yes">V</italic><sub>sample</sub>, from the sample of volume <italic toggle="yes">V</italic><sub>sample</sub>, is analogous to drawing balls out of a bag containing green and yellow balls, and considering green balls a success, and yellow ones a failure. It is a series of Bernoulli trials where</p>
        <list list-type="simple">
          <list-item>
            <p><italic toggle="yes">n</italic> = <italic toggle="yes">V</italic><sub><bold>inoc</bold></sub>/<italic toggle="yes">V</italic><sub><bold>vir</bold></sub> is the number of draws, i.e., the number of virion-size volumes (<italic toggle="yes">V</italic><sub>vir</sub>) drawn from the sample to form the inoculum volume (<italic toggle="yes">V</italic><sub>inoc</sub>), analogous to the number of balls drawn.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">k</italic> is the number of successes, i.e., the number of infectious virions drawn from the sample to form the inoculum, analogous to the number of green balls drawn.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">p</italic> is the probability of success, i.e., the fraction of virion-size volumes in the sample that are occupied by infectious virions, analogous to the probability of drawing a green ball.</p>
          </list-item>
        </list>
        <p>The probability of success, <italic toggle="yes">p</italic>, is related to the concentration of infectious virus in the sample, <italic toggle="yes">C</italic><sub>inf</sub>, as
<disp-formula id="pcbi.1009480.e018"><alternatives><graphic xlink:href="pcbi.1009480.e018.jpg" id="pcbi.1009480.e018g" position="anchor"/><mml:math id="M18" display="block" overflow="scroll"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Number</mml:mtext><mml:mspace width="4pt"/><mml:mtext>of</mml:mtext><mml:mspace width="4pt"/><mml:mtext>virions</mml:mtext><mml:mspace width="4pt"/><mml:mtext>in</mml:mtext><mml:mspace width="4pt"/><mml:mtext>sample</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Number</mml:mtext><mml:mspace width="4pt"/><mml:mtext>of</mml:mtext><mml:mspace width="4pt"/><mml:mtext>virion-size</mml:mtext><mml:mspace width="4pt"/><mml:mtext>volumes</mml:mtext><mml:mspace width="4pt"/><mml:mtext>in</mml:mtext><mml:mspace width="4pt"/><mml:mtext>the</mml:mtext><mml:mspace width="4pt"/><mml:mtext>sample</mml:mtext></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>sample</mml:mtext></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mtext>sample</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
where <italic toggle="yes">C</italic><sub>inf</sub> is the quantity we aim to estimate. Unlike the ball analogy where it is easy to count how many green balls <italic toggle="yes">k</italic> were drawn, after having drawn <italic toggle="yes">n</italic> virion-size volumes from the sample into our inoculum, we cannot count how many infectious virions were drawn into the inoculum. However, if this inoculum is deposited onto a susceptible cell culture, we can observe whether or not infection occurs, and this would indicate that the inoculum contained at least one or more infectious virions. Note that, as explained in the <xref rid="sec001" ref-type="sec">Introduction</xref>, even a productively infectious virion, i.e., one capable of completing the full virus replication from attachment to progeny release, might not result in a productive infection. As such, from hereon, <italic toggle="yes">C</italic><sub>inf</sub> is used to designate the concentration of specific infections in the sample, which is smaller or equal to the concentration of infectious virions, i.e., measures the subset of the infectious virions.</p>
        <p>Having deposited the inoculum into one well of the 96-well plate of our ED experiment, the likelihood that the well will <italic toggle="yes">not</italic> become infected, <italic toggle="yes">q</italic><sub>noinf</sub>, corresponds to the likelihood of having drawn <italic toggle="yes">k</italic> = 0 infectious virions (or rather, specific infections) out of the <italic toggle="yes">n</italic> virion volumes that make up our inoculum, namely
<disp-formula id="pcbi.1009480.e019"><alternatives><graphic xlink:href="pcbi.1009480.e019.jpg" id="pcbi.1009480.e019g" position="anchor"/><mml:math id="M19" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mtext>Binomial</mml:mtext><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>|</mml:mo><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>n</mml:mi><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>!</mml:mo><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mi>p</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula>
where <italic toggle="yes">q</italic><sub>noinf</sub> can be simplified by realizing that
<disp-formula id="pcbi.1009480.e020"><alternatives><graphic xlink:href="pcbi.1009480.e020.jpg" id="pcbi.1009480.e020g" position="anchor"/><mml:math id="M20" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>ln</mml:mtext><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mover><mml:mo>=</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>x</mml:mi><mml:mo>|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mover><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mn>2</mml:mn></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msup><mml:mi>x</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:mn>3</mml:mn></mml:mfrac><mml:mo>-</mml:mo><mml:mo>…</mml:mo><mml:mover><mml:mo>≈</mml:mo><mml:mrow><mml:mo>|</mml:mo><mml:mi>x</mml:mi><mml:mo>|</mml:mo><mml:mo>≪</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mover><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>ln</mml:mtext><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mfrac><mml:mspace width="4pt"/><mml:mtext>ln</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:mfrac><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mfrac><mml:mspace width="4pt"/><mml:mrow><mml:mo>(</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></p>
        <p>As such,
<disp-formula id="pcbi.1009480.e021"><alternatives><graphic xlink:href="pcbi.1009480.e021.jpg" id="pcbi.1009480.e021g" position="anchor"/><mml:math id="M21" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:msup><mml:mo>≈</mml:mo><mml:mtext>exp</mml:mtext><mml:mo>[</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula>
where <italic toggle="yes">q</italic><sub>noinf</sub> and (<italic toggle="yes">C</italic><sub>inf</sub>
<italic toggle="yes">V</italic><sub>vir</sub>) ∈ [0, 1] because <italic toggle="yes">C</italic><sub>inf</sub> = <italic toggle="yes">N</italic><sub>vir</sub>/<italic toggle="yes">V</italic><sub>sample</sub> and the number of specific infections in the sample, <italic toggle="yes">N</italic><sub>vir</sub>, is at a minimum zero, and at most the maximum number of virion-size volumes that can physically fit in the sample volume, namely <italic toggle="yes">V</italic><sub>sample</sub>/<italic toggle="yes">V</italic><sub>vir</sub>. As such, the maximum possible infection concentration, given a sample of volume <italic toggle="yes">V</italic><sub>sample</sub>, is <italic toggle="yes">C</italic><sub>inf</sub> = (<italic toggle="yes">V</italic><sub>sample</sub>/<italic toggle="yes">V</italic><sub>vir</sub>)/<italic toggle="yes">V</italic><sub>sample</sub> = 1/<italic toggle="yes">V</italic><sub>vir</sub>, and <italic toggle="yes">C</italic><sub>inf</sub> ∈ [0,1/<italic toggle="yes">V</italic><sub>vir</sub>].</p>
      </sec>
      <sec id="sec011">
        <title>Considering replicate wells at a given dilution</title>
        <p>The ED assay is based on serial dilutions of the sample, with each dilution separated by a fixed dilution factor. We define the dilution factor ∈ (0,1) as the fraction of the inoculum volume drawn from the previous dilution. For example, if the inoculum for a well, <italic toggle="yes">V</italic><sub>inoc</sub> = 100 μL, comprises 10 μL drawn from the previous dilution and 90 μL of dilution media, the dilution factor is 10/100 = 0.1. If the serial dilution begins with a dilution of <inline-formula id="pcbi.1009480.e022"><alternatives><graphic xlink:href="pcbi.1009480.e022.jpg" id="pcbi.1009480.e022g" position="anchor"/><mml:math id="M22" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>, then the following dilution will be <inline-formula id="pcbi.1009480.e023"><alternatives><graphic xlink:href="pcbi.1009480.e023.jpg" id="pcbi.1009480.e023g" position="anchor"/><mml:math id="M23" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>02</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. In <xref rid="pcbi.1009480.e019" ref-type="disp-formula">Eq (1)</xref>, the dilution under consideration, <inline-formula id="pcbi.1009480.e024"><alternatives><graphic xlink:href="pcbi.1009480.e024.jpg" id="pcbi.1009480.e024g" position="anchor"/><mml:math id="M24" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, will affect <italic toggle="yes">n</italic>, the number of virion-sized volumes drawn from the sample and deposited into the wells of the <italic toggle="yes">i</italic><sup>th</sup> dilution, such that now <inline-formula id="pcbi.1009480.e025"><alternatives><graphic xlink:href="pcbi.1009480.e025.jpg" id="pcbi.1009480.e025g" position="anchor"/><mml:math id="M25" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>. Therefore, the probability that a well at the <italic toggle="yes">i</italic><sup>th</sup> dilution will <italic toggle="yes">not</italic> become infected is given by
<disp-formula id="pcbi.1009480.e026"><alternatives><graphic xlink:href="pcbi.1009480.e026.jpg" id="pcbi.1009480.e026g" position="anchor"/><mml:math id="M26" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>≡</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msubsup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:msup><mml:mo>≈</mml:mo><mml:mtext>exp</mml:mtext><mml:mo>[</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>]</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula>
where 1 − <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub> is the probability of infection for a well at the <italic toggle="yes">i</italic><sup>th</sup> dilution, where <inline-formula id="pcbi.1009480.e027"><alternatives><graphic xlink:href="pcbi.1009480.e027.jpg" id="pcbi.1009480.e027g" position="anchor"/><mml:math id="M27" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>.</p>
        <p>When conducting an ED assay, each dilution in the assay contains a number of independent infection wells (replicates), all inoculated with the same dilution, <inline-formula id="pcbi.1009480.e028"><alternatives><graphic xlink:href="pcbi.1009480.e028.jpg" id="pcbi.1009480.e028g" position="anchor"/><mml:math id="M28" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>. This is analogous again to drawing balls out of a bag, but this time there are <italic toggle="yes">n</italic><sub><italic toggle="yes">i</italic></sub> draws (replicate wells), and the probability of success (i.e., that a well becomes infected) is simply one minus the probability of failure (i.e., that a well does not become infected, <italic toggle="yes">q</italic><sub><italic toggle="yes">i</italic></sub>). The probability that <italic toggle="yes">k</italic><sub><italic toggle="yes">i</italic></sub> out of the <italic toggle="yes">n</italic><sub><italic toggle="yes">i</italic></sub> wells become infected at dilution <inline-formula id="pcbi.1009480.e029"><alternatives><graphic xlink:href="pcbi.1009480.e029.jpg" id="pcbi.1009480.e029g" position="anchor"/><mml:math id="M29" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, is described by the Binomial distribution
<disp-formula id="pcbi.1009480.e030"><alternatives><graphic xlink:href="pcbi.1009480.e030.jpg" id="pcbi.1009480.e030g" position="anchor"/><mml:math id="M30" display="block" overflow="scroll"><mml:mrow><mml:mtext>Binomial</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>!</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:mspace width="0.166667em"/><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:msubsup><mml:mo>∝</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></disp-formula>
where <italic toggle="yes">n</italic><sub><italic toggle="yes">i</italic></sub> is the number of replicate wells at each dilution, but could be less if any well at dilution <inline-formula id="pcbi.1009480.e031"><alternatives><graphic xlink:href="pcbi.1009480.e031.jpg" id="pcbi.1009480.e031g" position="anchor"/><mml:math id="M31" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula> are spoiled or contaminated.</p>
        <p>However, our interest is not in determining <italic toggle="yes">k</italic><sub>1</sub> given <italic toggle="yes">q</italic><sub>noinf</sub>, but rather in determining <italic toggle="yes">q</italic><sub>noinf</sub> given that we observed <italic toggle="yes">k</italic><sub>1</sub> infected wells out of <italic toggle="yes">n</italic><sub>1</sub> wells in the first column. To this aim, we can make use of Bayes’ theorem which, in our context, can be expressed as
<disp-formula id="pcbi.1009480.e032"><alternatives><graphic xlink:href="pcbi.1009480.e032.jpg" id="pcbi.1009480.e032g" position="anchor"/><mml:math id="M32" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>|</mml:mo><mml:mtext>data</mml:mtext><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="script">P</mml:mi><mml:mo>(</mml:mo><mml:mtext>data</mml:mtext><mml:mo>|</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo><mml:mspace width="4pt"/><mml:mi mathvariant="script">P</mml:mi><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mn>0</mml:mn><mml:mn>1</mml:mn></mml:msubsup><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mtext>data</mml:mtext><mml:mo>|</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>p</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">d</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>
or rather
<disp-formula id="pcbi.1009480.e033"><alternatives><graphic xlink:href="pcbi.1009480.e033.jpg" id="pcbi.1009480.e033g" position="anchor"/><mml:math id="M33" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,1</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mn>0</mml:mn><mml:mn>1</mml:mn></mml:msubsup><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo><mml:mspace width="0.166667em"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mn>0</mml:mn><mml:mn>1</mml:mn></mml:msubsup><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,1</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>∝</mml:mo><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo><mml:mspace width="0.166667em"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
where <inline-formula id="pcbi.1009480.e034"><alternatives><graphic xlink:href="pcbi.1009480.e034.jpg" id="pcbi.1009480.e034g" position="anchor"/><mml:math id="M34" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,1</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> is our updated, posterior belief about <italic toggle="yes">q</italic><sub>noinf</sub> after having observed <italic toggle="yes">k</italic><sub>1</sub> successes out of <italic toggle="yes">n</italic><sub>1</sub> trials in the first column (<italic toggle="yes">i</italic> = 1), and given our prior belief, <inline-formula id="pcbi.1009480.e035"><alternatives><graphic xlink:href="pcbi.1009480.e035.jpg" id="pcbi.1009480.e035g" position="anchor"/><mml:math id="M35" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, about <italic toggle="yes">q</italic><sub>noinf</sub> before making this observation.</p>
      </sec>
      <sec id="sec012">
        <title>Considering all dilutions of the ED assay</title>
        <p>As mentioned above, in the 96-well ED assay, each dilution contains a number of independent infection wells (replicates) inoculated with the same sample concentration. This process is then repeated over a series of dilutions, each separated from the previous by a fixed dilution factor. Having observed the fraction of wells infected at the first dilution considered, <inline-formula id="pcbi.1009480.e036"><alternatives><graphic xlink:href="pcbi.1009480.e036.jpg" id="pcbi.1009480.e036g" position="anchor"/><mml:math id="M36" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>, we have updated our posterior belief about <italic toggle="yes">q</italic><sub>noinf</sub>. We will now use this updated belief as our new prior as we observe our second dilution (<inline-formula id="pcbi.1009480.e037"><alternatives><graphic xlink:href="pcbi.1009480.e037.jpg" id="pcbi.1009480.e037g" position="anchor"/><mml:math id="M37" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>), such that
<disp-formula id="pcbi.1009480.e038"><alternatives><graphic xlink:href="pcbi.1009480.e038.jpg" id="pcbi.1009480.e038g" position="anchor"/><mml:math id="M38" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,2</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,1</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,2</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>∝</mml:mo><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi>D</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo><mml:mspace width="0.166667em"/><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,2</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
where we introduce <inline-formula id="pcbi.1009480.e039"><alternatives><graphic xlink:href="pcbi.1009480.e039.jpg" id="pcbi.1009480.e039g" position="anchor"/><mml:math id="M39" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> and
<disp-formula id="pcbi.1009480.e040"><alternatives><graphic xlink:href="pcbi.1009480.e040.jpg" id="pcbi.1009480.e040g" position="anchor"/><mml:math id="M40" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi>D</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo><mml:mspace width="0.166667em"/><mml:mo>[</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>]</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
as short-hands for convenience. From this, it is easy to extrapolate the posterior distribution after having observed all <italic toggle="yes">J</italic> dilutions (<inline-formula id="pcbi.1009480.e041"><alternatives><graphic xlink:href="pcbi.1009480.e041.jpg" id="pcbi.1009480.e041g" position="anchor"/><mml:math id="M41" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>J</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) of the ED assay, namely
<disp-formula id="pcbi.1009480.e042"><alternatives><graphic xlink:href="pcbi.1009480.e042.jpg" id="pcbi.1009480.e042g" position="anchor"/><mml:math id="M42" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>post,J</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula>
where
<disp-formula id="pcbi.1009480.e043"><alternatives><graphic xlink:href="pcbi.1009480.e043.jpg" id="pcbi.1009480.e043g" position="anchor"/><mml:math id="M43" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>[</mml:mo><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>J</mml:mi></mml:munderover><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msup><mml:mo>]</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>J</mml:mi></mml:msubsup><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula></p>
        <p>Note that this expression is largely equivalent to that obtained by Mistry et al. [<xref rid="pcbi.1009480.ref008" ref-type="bibr">8</xref>] in the context of estimating the TCID<sub>50</sub> of a virus sample, and by many others in the broader context of infection dose quantification [<xref rid="pcbi.1009480.ref012" ref-type="bibr">12</xref>, <xref rid="pcbi.1009480.ref013" ref-type="bibr">13</xref>].</p>
      </sec>
      <sec id="sec013">
        <title>Considering the choice of prior</title>
        <p>In <xref rid="pcbi.1009480.e042" ref-type="disp-formula">Eq (4)</xref>, we obtained a posterior for <italic toggle="yes">q</italic><sub>noinf</sub>. Our objective, however, is to estimate the posterior distribution for <italic toggle="yes">C</italic><sub>inf</sub>, the specific infection concentration in our sample, rather than <italic toggle="yes">q</italic><sub>noinf</sub>. In fact, because both the plaque and ED assays provide an accuracy that is normally distributed in log<sub>10</sub>(<italic toggle="yes">C</italic><sub>inf</sub>) rather than <italic toggle="yes">C</italic><sub>inf</sub>, it follows that log<sub>10</sub>(<italic toggle="yes">C</italic><sub>inf</sub>) (hereafter <italic toggle="yes">ℓ</italic><sub>Cinf</sub>) rather than <italic toggle="yes">C</italic><sub>inf</sub> is the quantity of interest. We note that <inline-formula id="pcbi.1009480.e044"><alternatives><graphic xlink:href="pcbi.1009480.e044.jpg" id="pcbi.1009480.e044g" position="anchor"/><mml:math id="M44" display="inline" overflow="scroll"><mml:mrow><mml:mi mathvariant="script">Q</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> in <xref rid="pcbi.1009480.e042" ref-type="disp-formula">Eq (4)</xref> is a probability density function in <inline-formula id="pcbi.1009480.e045"><alternatives><graphic xlink:href="pcbi.1009480.e045.jpg" id="pcbi.1009480.e045g" position="anchor"/><mml:math id="M45" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>J</mml:mi></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, rather than in <italic toggle="yes">q</italic><sub>noinf</sub>. As such, a change of variables from <italic toggle="yes">q</italic><sub>noinf</sub> to <italic toggle="yes">ℓ</italic><sub>Cinf</sub> would affect only the prior, because <inline-formula id="pcbi.1009480.e046"><alternatives><graphic xlink:href="pcbi.1009480.e046.jpg" id="pcbi.1009480.e046g" position="anchor"/><mml:math id="M46" display="inline" overflow="scroll"><mml:mrow><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. Thus, the posterior distribution for <italic toggle="yes">ℓ</italic><sub>Cinf</sub> is given by
<disp-formula id="pcbi.1009480.e047"><alternatives><graphic xlink:href="pcbi.1009480.e047.jpg" id="pcbi.1009480.e047g" position="anchor"/><mml:math id="M47" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mtext>post</mml:mtext><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula></p>
        <p>To complete this expression, we need to choose a physically and biologically appropriate prior belief regarding <italic toggle="yes">ℓ</italic><sub>Cinf</sub>. Prior to conducting the ED assay, we know at least that <italic toggle="yes">C</italic><sub>inf</sub> ∈ [1/<italic toggle="yes">V</italic><sub>Earth</sub>,1/<italic toggle="yes">V</italic><sub>vir</sub>], where 1/<italic toggle="yes">V</italic><sub>vir</sub> is the maximum possible concentration, namely that if the entire volume of the sample is constituted solely of infectious virions, and 1/<italic toggle="yes">V</italic><sub>Earth</sub> is the minimum possible concentration, namely that if there was only one infectious virion left on Earth. As we explain below, these limits are not important; only the fact that they are convincingly physically bounded both from above and below, i.e., ∈ (0, ∞), is relevant.</p>
        <p>If we choose our prior to be uniform in <italic toggle="yes">C</italic><sub>inf</sub> ∈ [1/<italic toggle="yes">V</italic><sub>Earth</sub>,1/<italic toggle="yes">V</italic><sub>vir</sub>], namely <inline-formula id="pcbi.1009480.e048"><alternatives><graphic xlink:href="pcbi.1009480.e048.jpg" id="pcbi.1009480.e048g" position="anchor"/><mml:math id="M48" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>Earth</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>, and using the fact that <inline-formula id="pcbi.1009480.e049"><alternatives><graphic xlink:href="pcbi.1009480.e049.jpg" id="pcbi.1009480.e049g" position="anchor"/><mml:math id="M49" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.166667em"/><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>, we can write
<disp-formula id="pcbi.1009480.e050"><alternatives><graphic xlink:href="pcbi.1009480.e050.jpg" id="pcbi.1009480.e050g" position="anchor"/><mml:math id="M50" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mtext>prior</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mtext>inf</mml:mtext></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>[</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:msup><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>vir</mml:mtext></mml:msub><mml:mspace width="4pt"/><mml:mtext>ln</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>10</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:msup><mml:mo>∝</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>
which yields
<disp-formula id="pcbi.1009480.e051"><alternatives><graphic xlink:href="pcbi.1009480.e051.jpg" id="pcbi.1009480.e051g" position="anchor"/><mml:math id="M51" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mtext>post</mml:mtext><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:msup><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula></p>
        <p>We see here that the range chosen for the uniform prior in <italic toggle="yes">C</italic><sub>inf</sub> is not important because it only contributes a constant to our proportionality <xref rid="pcbi.1009480.e047" ref-type="disp-formula">Eq (6)</xref>.</p>
        <p>Alternatively, because the ED assay estimates <italic toggle="yes">ℓ</italic><sub>Cinf</sub> rather than <italic toggle="yes">C</italic><sub>inf</sub>, our prior belief about the virus concentration is more appropriately expressed in <italic toggle="yes">ℓ</italic><sub>Cinf</sub> rather than <italic toggle="yes">C</italic><sub>inf</sub>. Again, the bounds of the uniform distribution in <italic toggle="yes">ℓ</italic><sub>Cinf</sub> is unimportant, provided that it is finite in extent such that <inline-formula id="pcbi.1009480.e067"><alternatives><graphic xlink:href="pcbi.1009480.e067.jpg" id="pcbi.1009480.e067g" position="anchor"/><mml:math id="M67" display="inline" overflow="scroll"><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mtext>min</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mtext>log</mml:mtext></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mfenced><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mtext>vir</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:math></alternatives></inline-formula> where <inline-formula id="pcbi.1009480.e068"><alternatives><graphic xlink:href="pcbi.1009480.e068.jpg" id="pcbi.1009480.e068g" position="anchor"/><mml:math id="M68" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mtext>min</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mo>−</mml:mo><mml:mo>∞</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, such that we can write
<disp-formula id="pcbi.1009480.e052"><alternatives><graphic xlink:href="pcbi.1009480.e052.jpg" id="pcbi.1009480.e052g" position="anchor"/><mml:math id="M52" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mtext>post</mml:mtext><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mi mathvariant="script">Q</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mtext>noinf</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula></p>
        <p><xref rid="pcbi.1009480.g008" ref-type="fig">Fig 8</xref> illustrates the two distinct priors assumed to arrive at Eqs (<xref rid="pcbi.1009480.e051" ref-type="disp-formula">7</xref>) and (<xref rid="pcbi.1009480.e052" ref-type="disp-formula">8</xref>) and their impact on the posterior <inline-formula id="pcbi.1009480.e053"><alternatives><graphic xlink:href="pcbi.1009480.e053.jpg" id="pcbi.1009480.e053g" position="anchor"/><mml:math id="M53" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">P</mml:mi><mml:mrow><mml:mtext>post</mml:mtext><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> for the example ED experiment described in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1</xref>. <xref rid="pcbi.1009480.g008" ref-type="fig">Fig 8A</xref> illustrates the consequence of choosing a prior uniform in <italic toggle="yes">C</italic><sub>inf</sub>, i.e., a bias towards higher virus concentrations. This is because a uniform prior in <italic toggle="yes">C</italic><sub>inf</sub> corresponds to a belief that one is as likely to measure a set of virus concentrations in the range [0.001, 0.002] as in the range [1,000, 000.001, 1, 000, 000.002]. When plotted on a log-scale, there are 100× more intervals of width 0.001 in [10<sup>4</sup>, 10<sup>5</sup>] than in [10<sup>2</sup>, 10<sup>3</sup>]. Thus, this prior corresponds to a belief that the likelihood of measuring a certain virus concentration increases exponentially as <italic toggle="yes">ℓ</italic><sub>Cinf</sub> increases linearly. In contrast, a prior uniform in <italic toggle="yes">ℓ</italic><sub>Cinf</sub> corresponds to a belief that one is as likely to measure a set of virus concentrations in the range [0.001, 0.002] as in the range [1, 000, 000, 2, 000, 000], or rather in the range [1, 2] × 10<sup>−3</sup> as in the range [1, 2] × 10<sup>6</sup>. As such, a uniform distribution in <italic toggle="yes">ℓ</italic><sub>Cinf</sub> is more physically and biologically sensible and therefore was chosen for our estimation method.</p>
        <fig position="float" id="pcbi.1009480.g008">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1009480.g008</object-id>
          <label>Fig 8</label>
          <caption>
            <title>Impact of the choice of prior on the posterior distribution for <italic toggle="yes">ℓ</italic><sub>Cinf</sub>.</title>
            <p>A: Non-normalized priors for log<sub>10</sub>(specific infections, SIN/mL) = <italic toggle="yes">ℓ</italic><sub>Cinf</sub> that are uniform in either <italic toggle="yes">C</italic><sub>inf</sub> or <italic toggle="yes">ℓ</italic><sub>Cinf</sub> are shown. A prior uniform in <italic toggle="yes">C</italic><sub>inf</sub> is biased towards larger values of <italic toggle="yes">ℓ</italic><sub>Cinf</sub>. B: Updated posterior belief about <italic toggle="yes">ℓ</italic><sub>Cinf</sub> for each of the two prior beliefs shown in A, as per Eqs (<xref rid="pcbi.1009480.e051" ref-type="disp-formula">7</xref>) and (<xref rid="pcbi.1009480.e052" ref-type="disp-formula">8</xref>), after having observed the ED assay example provided in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1</xref>. While the prior uniform in <italic toggle="yes">C</italic><sub>inf</sub> yields a posterior with a mode of <italic toggle="yes">ℓ</italic><sub>Cinf</sub> = 6.21, that for a prior uniform in <italic toggle="yes">ℓ</italic><sub>Cinf</sub> yields a mode of <italic toggle="yes">ℓ</italic><sub>Cinf</sub> = 6.18.</p>
          </caption>
          <graphic xlink:href="pcbi.1009480.g008" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec id="sec014">
      <title>Calculation of midSIN’s outputs</title>
      <p>One of the graphical outputs of <bold>midSIN</bold> is the non-normalized posterior distribution of <italic toggle="yes">ℓ</italic><sub>Cinf</sub> given the number of wells that were infected at each dilution, <inline-formula id="pcbi.1009480.e054"><alternatives><graphic xlink:href="pcbi.1009480.e054.jpg" id="pcbi.1009480.e054g" position="anchor"/><mml:math id="M54" display="inline" overflow="scroll"><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub></mml:math></alternatives></inline-formula>, like that shown in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1</xref>(left panel), computed as
<disp-formula id="pcbi.1009480.e055"><alternatives><graphic xlink:href="pcbi.1009480.e055.jpg" id="pcbi.1009480.e055g" position="anchor"/><mml:math id="M55" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">U</mml:mi><mml:mtext>post</mml:mtext></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mspace width="0.166667em"/><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:mo>|</mml:mo><mml:mspace width="0.166667em"/><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub><mml:mspace width="0.166667em"/><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>J</mml:mi></mml:munderover><mml:mspace width="4pt"/><mml:mfrac><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>!</mml:mo><mml:mspace width="4pt"/><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:mspace width="4pt"/><mml:mo>·</mml:mo><mml:mspace width="4pt"/><mml:msubsup><mml:mi>p</mml:mi><mml:mi>j</mml:mi><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msubsup><mml:mspace width="4pt"/><mml:mo>·</mml:mo><mml:mspace width="4pt"/><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula>
where
<disp-formula id="pcbi.1009480.e056"><alternatives><graphic xlink:href="pcbi.1009480.e056.jpg" id="pcbi.1009480.e056g" position="anchor"/><mml:math id="M56" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mtext>exp</mml:mtext><mml:mo>[</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mtext>Cinf</mml:mtext></mml:msub></mml:msup><mml:mo>·</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mo>·</mml:mo><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mspace width="4pt"/><mml:mo>]</mml:mo><mml:mspace width="4pt"/><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(10)</label></disp-formula></p>
      <p>While <inline-formula id="pcbi.1009480.e057"><alternatives><graphic xlink:href="pcbi.1009480.e057.jpg" id="pcbi.1009480.e057g" position="anchor"/><mml:math id="M57" display="inline" overflow="scroll"><mml:msub><mml:mi mathvariant="script">U</mml:mi><mml:mtext>post</mml:mtext></mml:msub></mml:math></alternatives></inline-formula> is not the normalized posterior distribution for <italic toggle="yes">ℓ</italic><sub>Cinf</sub>, its maximum value at its mode (<inline-formula id="pcbi.1009480.e069"><alternatives><graphic xlink:href="pcbi.1009480.e069.jpg" id="pcbi.1009480.e069g" position="anchor"/><mml:math id="M69" display="inline" overflow="scroll"><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mo>,</mml:mo><mml:mtext>mode</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>) is the normalized probability of observing this particular ED plate outcome (<inline-formula id="pcbi.1009480.e058"><alternatives><graphic xlink:href="pcbi.1009480.e058.jpg" id="pcbi.1009480.e058g" position="anchor"/><mml:math id="M58" display="inline" overflow="scroll"><mml:msub><mml:mover accent="true"><mml:mi>k</mml:mi><mml:mo>→</mml:mo></mml:mover><mml:mi>J</mml:mi></mml:msub></mml:math></alternatives></inline-formula>) out of all other possible plate outcomes, assuming the true, specific infection concentration in the sample is <inline-formula id="pcbi.1009480.e070"><alternatives><graphic xlink:href="pcbi.1009480.e070.jpg" id="pcbi.1009480.e070g" position="anchor"/><mml:math id="M70" display="inline" overflow="scroll"><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mo>,</mml:mo><mml:mtext>mode</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>.</p>
      <p>Another visual output of <bold>midSIN</bold> is a graphical representation of the theoretical number of wells that would be infected given the most likely <italic toggle="yes">ℓ</italic><sub>Cinf</sub>, like that shown in <xref rid="pcbi.1009480.g001" ref-type="fig">Fig 1</xref>(right panel). It is computed following
<disp-formula id="pcbi.1009480.e059"><alternatives><graphic xlink:href="pcbi.1009480.e059.jpg" id="pcbi.1009480.e059g" position="anchor"/><mml:math id="M59" display="block" overflow="scroll"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mtext>wells</mml:mtext><mml:mspace width="4pt"/><mml:mtext>infected</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mtext>wells</mml:mtext><mml:mspace width="4pt"/><mml:mtext>total</mml:mtext></mml:mrow></mml:msub><mml:mo>[</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mtext>exp</mml:mtext><mml:mo>(</mml:mo><mml:mo>-</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext><mml:msub><mml:mo>,</mml:mo><mml:mrow><mml:mtext>mode</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:msup><mml:mspace width="0.166667em"/><mml:msub><mml:mi>V</mml:mi><mml:mtext>inoc</mml:mtext></mml:msub><mml:mspace width="0.166667em"/><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo><mml:mo>]</mml:mo><mml:mspace width="4pt"/><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(11)</label></disp-formula>
where <italic toggle="yes">x</italic> is the log<sub>10</sub> of the dilution such that <inline-formula id="pcbi.1009480.e060"><alternatives><graphic xlink:href="pcbi.1009480.e060.jpg" id="pcbi.1009480.e060g" position="anchor"/><mml:math id="M60" display="inline" overflow="scroll"><mml:mrow><mml:mi mathvariant="script">D</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is the dilution. It corresponds to the continuous equivalent of this quantity which is discrete in the ED assay, namely <inline-formula id="pcbi.1009480.e061"><alternatives><graphic xlink:href="pcbi.1009480.e061.jpg" id="pcbi.1009480.e061g" position="anchor"/><mml:math id="M61" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> which is the <italic toggle="yes">i</italic><sup>th</sup> dilution of the sample. As such, <inline-formula id="pcbi.1009480.e062"><alternatives><graphic xlink:href="pcbi.1009480.e062.jpg" id="pcbi.1009480.e062g" position="anchor"/><mml:math id="M62" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo></mml:mrow><mml:mo>(</mml:mo><mml:mtext>minimum</mml:mtext><mml:mspace width="4pt"/><mml:mtext>dilution</mml:mtext><mml:mo>)</mml:mo><mml:mo>⋅</mml:mo><mml:mo>(</mml:mo><mml:mtext>dilution</mml:mtext><mml:mspace width="4pt"/><mml:mtext>factor</mml:mtext><mml:mspace width="4pt"/><mml:mtext>between</mml:mtext><mml:mspace width="4pt"/><mml:mtext>columns</mml:mtext><mml:msup><mml:mo>)</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula> where <italic toggle="yes">i</italic> ∈ [1, <italic toggle="yes">J</italic>]. For example, if the dilution of the least diluted column is 0.1 = 10<sup>−1</sup> and the dilution factor between dilutions in the ED assay is such that it halves the concentration between each dilution, i.e., <inline-formula id="pcbi.1009480.e073"><alternatives><graphic xlink:href="pcbi.1009480.e073.jpg" id="pcbi.1009480.e073g" position="anchor"/><mml:math id="M73" display="inline" overflow="scroll"><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mo>−</mml:mo></mml:msup><mml:msup><mml:mrow/><mml:mrow><mml:msub><mml:mrow><mml:mtext>log</mml:mtext></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>≈</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.301</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, then <inline-formula id="pcbi.1009480.e063"><alternatives><graphic xlink:href="pcbi.1009480.e063.jpg" id="pcbi.1009480.e063g" position="anchor"/><mml:math id="M63" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>·</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>301</mml:mn><mml:mo>·</mml:mo><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> such that <inline-formula id="pcbi.1009480.e064"><alternatives><graphic xlink:href="pcbi.1009480.e064.jpg" id="pcbi.1009480.e064g" position="anchor"/><mml:math id="M64" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pcbi.1009480.e065"><alternatives><graphic xlink:href="pcbi.1009480.e065.jpg" id="pcbi.1009480.e065g" position="anchor"/><mml:math id="M65" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>301</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pcbi.1009480.e066"><alternatives><graphic xlink:href="pcbi.1009480.e066.jpg" id="pcbi.1009480.e066g" position="anchor"/><mml:math id="M66" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="script">D</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo><mml:mn>602</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, and so on, such that <italic toggle="yes">x</italic><sub>1</sub> = 1, <italic toggle="yes">x</italic><sub>2</sub> = 1.301, <italic toggle="yes">x</italic><sub>3</sub> = 1.602, and so on.</p>
      <p>In the graphical representation of the ED assay, the edges of the grey bands flanking the theoretical blue curve correspond to <xref rid="pcbi.1009480.e059" ref-type="disp-formula">Eq (11)</xref> wherein <inline-formula id="pcbi.1009480.e072"><alternatives><graphic xlink:href="pcbi.1009480.e072.jpg" id="pcbi.1009480.e072g" position="anchor"/><mml:math id="M72" display="inline" overflow="scroll"><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mo>,</mml:mo><mml:mtext>mode</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> has been replaced by the 68% and 95% CI values for <italic toggle="yes">ℓ</italic><sub>Cinf</sub>. These CI bands <italic toggle="yes">do not</italic> correspond to the 68% and 95% CI of the expected number of infected wells at each dilution given <inline-formula id="pcbi.1009480.e071"><alternatives><graphic xlink:href="pcbi.1009480.e071.jpg" id="pcbi.1009480.e071g" position="anchor"/><mml:math id="M71" display="inline" overflow="scroll"><mml:msub><mml:mi>ℓ</mml:mi><mml:mrow><mml:mtext>Cinf</mml:mtext></mml:mrow></mml:msub><mml:msub><mml:mrow/><mml:mrow><mml:msub><mml:mrow/><mml:mrow><mml:mo>,</mml:mo><mml:mtext>mode</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>.</p>
      <p>The sample dilution corresponding to 1 TCID<sub>50</sub> estimated based on the biased RM and SK approximations (right panels) are converted to SIN (left panels) based on 1 TCID<sub>50</sub> = e<sup><italic toggle="yes">γ</italic>=0.5772</sup> SIN = 1.781 SIN [<xref rid="pcbi.1009480.ref005" ref-type="bibr">5</xref>, <xref rid="pcbi.1009480.ref006" ref-type="bibr">6</xref>]. In contrast, the log<sub>10</sub>(SIN/mL) computed by <bold>midSIN</bold> can be converted to a true (unbiased) estimate of log<sub>10</sub>(TCID<sub>50</sub>) using 1 TCID<sub>50</sub> = 1/ln(2) SIN = 1.44 SIN [<xref rid="pcbi.1009480.ref004" ref-type="bibr">4</xref>].</p>
    </sec>
    <sec id="sec015">
      <title>Infection concentration measures of influenza A virus samples</title>
      <sec id="sec016">
        <title>Cell culture</title>
        <p>Madin-Darby canine kidney cells (MDCKs) were cultured in growth media (complete MEM media with 5% heat-inactivated FBS), in tissue culture treated T75 flasks, at 37°C with 5% CO<sub>2</sub> and 95% relative humidity. Cells were split 1/10 every 3–4 days or upon reaching approximately 95% confluency. One passage of cells was expanded for use by both researchers in one experiment to quantify the 50% tissue culture infectious dose (TCID<sub>50</sub>) and plaque forming units (PFU) of one viral strain.</p>
      </sec>
      <sec id="sec017">
        <title>Viral stocks</title>
        <p>Stocks of influenza A/Puerto Rico/8/34 (H1N1) (PR8) and influenza A/California/4/09 (Cali/09) were stored at -80°C and thawed on ice immediately before use. The TCID<sub>50</sub> and PFU of stock viruses was known to both researchers prior to this study. Serial dilutions were made in MDCK infection media (complete MEM media with 4.25% BSA) and dilutions were made by each researcher independently for titering. ‘Researcher A’ and ‘Researcher B’ independently performed the TCID<sub>50</sub> and PFU assays of one viral strain for one experiment on the same day using the same viral stock, reagents, and passage of cells. Each experiment was performed on a separate day (<xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3</xref>).</p>
      </sec>
      <sec id="sec018">
        <title>Plaque assay</title>
        <p>MDCKs were seeded in six-well plates (5.5 × 10<sup>5</sup> cells/mL, 2 mL/well) and grown to 90% confluency overnight (37°C, 5% CO<sub>2</sub>, 95% relative humidity). Each six-well plate contained 10-fold serial dilutions plated in singlet as well as a negative control and five 6-well plates were carried out per experiment. Cells were washed twice with PBS containing Ca<sup>2+</sup>Mg<sup>2+</sup> (PBS w/ Ca<sup>2+</sup>Mg<sup>2+</sup>) (Gibco), before the addition of 500 μL of viral dilutions per well. After 1 h at room temperature on a rocker, the inoculum was aspirated, cells were washed with PBS w/ Ca<sup>2+</sup>Mg<sup>2+</sup>, and gently covered with 2 mL of agarose overlay (complete media, 4.25% BSA, 0.9% agarose, 1 μg/mL TPCK-Trypsin). After drying the overlay at room temperature, plates were inverted and incubated (37°C, 5% CO<sub>2</sub>, 95% relative humidity) for 3 d (PR8) or 4 d (Cali/09). Plaques were visualized by staining cells with 0.1% crystal violet solution in 37% formaldehyde for 30 min and counted by ‘Researcher A’ or ‘Researcher B’ on their respective experiments (<xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3</xref>).</p>
      </sec>
      <sec id="sec019">
        <title>TCID<sub>50</sub> assay</title>
        <p>MDCKs were seeded in 96-well flat bottom plates (5 × 10<sup>4</sup> cells/100 μL, 100 μL/well) and grown to 80% confluency overnight (37°C, 5% CO<sub>2</sub>, 95% relative humidity). For each experiment, 4 replicate wells, at each of 7 different dilutions separated by a 10-fold dilution, were infected, and the dilution series was performed 5 times. Cells were washed with PBS w/ Ca<sup>2+</sup>Mg<sup>2+</sup> before the addition of 100 μL of viral dilutions per well. After 1 h at room temperature on a rocker, the inoculum was aspirated and replaced with 100 μL of infection media containing 1 μg/mL TPCK-Trypsin. Cells were incubated (37°C, 5% CO<sub>2</sub>, 95% relative humidity) for 3 d (PR8) or 4 d (Cali/09). Supernatants from each of the MDCK-containing wells were transferred to a matching well in a 96-well U-bottom plate in the same configuration, and mixed with chicken red blood cells (30 min, room temperature). This enabled us to score each of the original MDCK-containing wells as either positive or negative for infection, based on whether their supernatant caused hemagglutination. This was performed and read by ‘Researcher A’ or ‘Researcher B’ on their respective experiments.</p>
      </sec>
      <sec id="sec020">
        <title>Statistical analysis</title>
        <p>The data points reported in <xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3C and 3D</xref> were computed by taking each of the 5 replicates measured with either the PFU, RM, or SK and the 5 replicates measured via SIN (5 replicates × 5 replicates = 25 pairs) for each of the 2 experiments by each of the 2 researchers, yielding 100 pairs. For each pair, the log<sub>10</sub> of ratio of either PFU, RM or SK over SIN was computed. The mean and standard deviation of the resulting 100 log<sub>10</sub>(ratio) were computed and are reported in <xref rid="pcbi.1009480.g003" ref-type="fig">Fig 3C and 3D</xref>. The statistical significance (<italic toggle="yes">p</italic>-value) of the differences between (PFU,RM,SK) and (SIN) was computed using the Mann-Whitney U test (<monospace>scipy.stats.mannwhitneyu</monospace>).</p>
      </sec>
    </sec>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="pcbi.1009480.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Spearman</surname><given-names>C</given-names></name>. <article-title>The method of “right and wrong cases” (constant stimuli) without Gauss’s formula</article-title>. <source>Br J Psychol</source>. <year>1908</year>;<volume>II</volume>(<issue>Part 3</issue>):<fpage>227</fpage>–<lpage>242</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.2044-8295.1908.tb00176.xref</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Kärber</surname><given-names>G</given-names></name>. <article-title>Beitrag zur kollecktiven behandlung pharmakologischer reihenversuche</article-title>. <source>Archiv f Experiment Pathol u Pharmakol</source>. <year>1931</year>;<volume>162</volume>(<issue>4</issue>):<fpage>480</fpage>–<lpage>483</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF01863914</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Reed</surname><given-names>LJ</given-names></name>, <name><surname>Muench</surname><given-names>H</given-names></name>. <article-title>A simple method of estimating fifty per cent endpoints</article-title>. <source>Am J Hygiene</source>. <year>1938</year>;<volume>27</volume>(<issue>3</issue>):<fpage>493</fpage>–<lpage>497</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Bryan</surname><given-names>WR</given-names></name>. <article-title>Interpretation of host response in quantitative studies on animal viruses</article-title>. <source>Ann N Y Acad Sci</source>. <year>1957</year>;<volume>69</volume>(<issue>4</issue>):<fpage>698</fpage>–<lpage>728</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1749-6632.1957.tb49710.x</pub-id><?supplied-pmid 13488325?><pub-id pub-id-type="pmid">13488325</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Wulff</surname><given-names>NH</given-names></name>, <name><surname>Tzatzaris</surname><given-names>M</given-names></name>, <name><surname>Young</surname><given-names>PJ</given-names></name>. <article-title>Monte Carlo simulation of the Spearman-Kaerber TCID50</article-title>. <source>J Clin Bioinforma</source>. <year>2012</year>;<volume>2</volume>(<issue>1</issue>):<fpage>5</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/2043-9113-2-5</pub-id><?supplied-pmid 22330733?><pub-id pub-id-type="pmid">22330733</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref006">
      <label>6</label>
      <mixed-citation publication-type="book"><name><surname>Govindarajulu</surname><given-names>Z</given-names></name>. <part-title>4. The Logit Approach</part-title>. In: <source>Statistical techniques in bioassay</source>. <edition designator="2">2nd ed</edition>. <publisher-loc>Basel; New York</publisher-loc>: <publisher-name>Karger</publisher-name>; <year>2001</year>. p. <fpage>35</fpage>–<lpage>90</lpage>.</mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>LaBarre</surname><given-names>DD</given-names></name>, <name><surname>Lowy</surname><given-names>RJ</given-names></name>. <article-title>Improvements in methods for calculating virus titer estimates from TCID<sub>50</sub> and plaque assays</article-title>. <source>J Virol Methods</source>. <year>2001</year>;<volume>96</volume>(<issue>2</issue>):<fpage>107</fpage>–<lpage>126</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0166-0934(01)00316-0</pub-id><?supplied-pmid 11445142?><pub-id pub-id-type="pmid">11445142</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Mistry</surname><given-names>BA</given-names></name>, <name><surname>D’Orsogna</surname><given-names>MR</given-names></name>, <name><surname>Chou</surname><given-names>T</given-names></name>. <article-title>The effects of statistical multiplicity of infection on virus quantification and infectivity assays</article-title>. <source>Biophys J</source>. <year>2018</year>;<volume>114</volume>(<issue>12</issue>):<fpage>2974</fpage>–<lpage>2985</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bpj.2018.05.005</pub-id><?supplied-pmid 29925033?><pub-id pub-id-type="pmid">29925033</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref009">
      <label>9</label>
      <mixed-citation publication-type="other">Mistry BA. Website application associated with [8];. Available from: <ext-link xlink:href="http://www.bhavenmistry.com/SMOI/" ext-link-type="uri">http://www.bhavenmistry.com/SMOI/</ext-link>.</mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref010">
      <label>10</label>
      <mixed-citation publication-type="other">Spouge JL. Website application associated with [12];. Available from: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/CBBresearch/Spouge/html_ncbi/html/id50/id50.cgi" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/CBBresearch/Spouge/html_ncbi/html/id50/id50.cgi</ext-link>.</mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Beauchemin</surname><given-names>CAA</given-names></name>, <name><surname>Kim</surname><given-names>YI</given-names></name>, <name><surname>Yu</surname><given-names>Q</given-names></name>, <name><surname>Ciaramella</surname><given-names>G</given-names></name>, <name><surname>DeVincenzo</surname><given-names>JP</given-names></name>. <article-title>Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses</article-title>. <source>PLOS ONE</source>. <year>2019</year>;<volume>14</volume>(<issue>4</issue>):<fpage>e0214708</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0214708</pub-id><?supplied-pmid 30986239?><pub-id pub-id-type="pmid">30986239</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Spouge</surname><given-names>JL</given-names></name>. <article-title>Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1992</year>;<volume>89</volume>(<issue>16</issue>):<fpage>7581</fpage>–<lpage>7585</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.89.16.7581</pub-id><?supplied-pmid 1323844?><pub-id pub-id-type="pmid">1323844</pub-id></mixed-citation>
    </ref>
    <ref id="pcbi.1009480.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Weir</surname><given-names>MH</given-names></name>, <name><surname>Mitchell</surname><given-names>J</given-names></name>, <name><surname>Flynn</surname><given-names>W</given-names></name>, <name><surname>Pope</surname><given-names>JM</given-names></name>. <article-title>Development of a microbial dose response visualization and modelling application for QMRA modelers and educators</article-title>. <source>Environ Model Softw</source>. <year>2017</year>;<volume>88</volume>:<fpage>74</fpage>–<lpage>83</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.envsoft.2016.11.011</pub-id><?supplied-pmid 29104445?><pub-id pub-id-type="pmid">29104445</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pcbi.1009480.r001" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009480.r001</article-id>
    <title-group>
      <article-title>Decision Letter 0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>De Boer</surname>
          <given-names>Rob J.</given-names>
        </name>
        <role>Deputy Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Regoes</surname>
          <given-names>Roland R</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 De Boer, Regoes</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>De Boer, Regoes</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1009480" id="rel-obj001" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>0</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">2 May 2021</named-content>
    </p>
    <p>Dear Dr. Beauchemin,</p>
    <p>Thank you very much for submitting your manuscript "Time to revisit the endpoint dilution assay and to replace TCID50 and PFU as measures of a virus sample's infection concentration" for consideration at PLOS Computational Biology.</p>
    <p>As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.</p>
    <p>Your paper was reviewed by an expert on the statistics of estimating ID50s, and two experimental virologists with a strong quantitative research agenda. The two experimental reviewers saw great value in the approach you are proposing. All reviewers agree that the paper could be improved by shortening it, focusing on describing your method. The more general parts on the various benefits or drawbacks of plaque-forming and dilutions assays could be skipped, especially because the experimentalists among the reviewers did not fully agree with the material presented. We also believe that your paper would improve by comparing your method to more recent advances in the estimation of TCID50 as Reed and Munch is outdated (although still used in some circles). Reviewer 1 gives a few starting references for a more comprehensive comparison with existing methods.</p>
    <p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p>
    <p>When you are ready to resubmit, please upload the following:</p>
    <p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
    <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
    <p>Important additional instructions are given below your reviewer comments.</p>
    <p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p>
    <p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
    <p>Sincerely,</p>
    <p>Roland R Regoes</p>
    <p>Associate Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Rob De Boer</p>
    <p>Deputy Editor</p>
    <p>PLOS Computational Biology</p>
    <p>***********************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: The article uses Bayesian probabilities to calculate the posterior probability distribution of the effective concentration of infectious particles in a viral stock. It also implements the calculation on the web. The article is unsuitable for publication in its present form. The authors should announce the software (e.g., Google “journal bioinformatics software”), confining their explanation to a few pages at most. The article omits an adequate survey of even rudimentary references. The end of the review lists some references relevant to similar problems in animal trials, not necessarily for citation, but as a start for searching for appropriate citations.</p>
    <p>Most of the authors’ explanation is unnecessary. The discussion of the relative merits of plaque-forming and dilutions assays, e.g., is irrelevant. Each type of assay has its merits and drawbacks, but the decision to use one or the other is subordinate to experimental means and ends. The article can therefore take the use of a dilution assay as dependent on ends, as a given. The article motivates itself with the Spearman-Karber and Reed-Muench methods. Although the methods still appear in the literature, they have been discredited for at least 30 years. The article’s notation also obscures the simplicity of its ideas. Psychological experiments have shown that mathematical subscripts should be single letters, preferably with mnemonic value, because lengthy subscripts slow readers’ comprehension. To appreciate the point, replace q[noinf] by q (without subscript) in all equations.</p>
    <p>The Bayesian probability model motivating the article is routine. Physically, infection is modeled by a Poisson likelihood. The article then gives a lengthy physical justification of the model prior. A routine non-informative prior may be preferable, but in any case, a Bayesian posterior should not be sensitive to the prior but depend mostly on the data. Any lengthy physical justification of the prior is therefore irrelevant.</p>
    <p>Here are the promised citations.</p>
    <p>Calculation of ID-50 <ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/26285041/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/26285041/</ext-link></p>
    <p>Infectious Particle Concentration <ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/1323844/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/1323844/</ext-link></p>
    <p>Harold Jeffreys "Theory of Probability" discusses non-informative priors, placing in context the unimportance of a "physical" Bayesian prior in statistical calculations.</p>
    <p>Reviewer #2: This paper describes a new and better method for computing viral titers from endpoint dilution assays. The method is accompanied by an online and downloadable calculator. As a virologist whose lab routinely performs TCID50s, I can say that the method used here is a substantial improvement, and is something I am going to start recommending to my group. I definitely think that based on its content, this paper deserves to be published in PLoS Computational Biology.</p>
    <p>That said, I have some pretty substantive suggested revisions. One of these is something that I think needs to be removed, and the others are my impression of things that need to be changed if the paper is going to be understood and well received by virologists.</p>
    <p>MAJOR COMMENTS:</p>
    <p>The paper makes two arguments: (1) endpoint dilutions assays such as TCID50 are better than plaque assays, and (2) the midSIN method is better than things like Reed-Muench for computing titers from endpoint dilution assays. The second of these points is definitely true, and forms the strong basis for the content of this paper. However, I don’t think the first point (superiority of endpoint dilution over plaque assay) is clearly established, nor do I think it’s at all necessary for this paper. I say this as someone who personally prefers endpoint dilution assays (TCID50) to plaque assay. But some virologists prefer plaque assays for a variety of reasons, including liking to see the plaques, the additional information they get from examining plaque sizes, etc. If I hadn’t read all the way through because I was a reviewer, I would have dismissed this paper after the first few paragraphs as an opinion piece arguing for TCID50 over plaque assays, and not paid attention to any of the rest. I strongly recommend the authors focus on what they clearly objectively demonstrate (that the midSIN method is better than alternatives for computing endpoint titers), and dispense with the more subjective arguments based on experimental factors that make them personally prefer endpoint assays to plaque assays.</p>
    <p>I think the paper would benefit from a clearer “intuitive layman’s explanation” of what exactly is wrong with the Reed-Muench formula compared to midSIN. Right now there is little explanation in main text, and then highly technical details in Methods but not good bridging of these.</p>
    <p>Although this is more a stylistic comment and one that is ultimately at the authors’ discretion, I’d suggest that the paper will have more impact if it’s more succinct, has less vague discussion of experiments and philosophical issues of titers, and really cuts more quickly to the heart of the issue which is that they have an improved way to calculate endpoint titers, they have implemented a calculator, and that their method allows calculation of how experimental choices (like dilution factor, number of dilution series, etc) affect accuracy.</p>
    <p>MINOR COMMENTS:</p>
    <p>The number of acronyms introduced just in the abstract (RM, SK, etc) becomes overwhelming and decreases readability. Maybe some of the less commonly used acronyms could be eliminated in favor of just writing out the full phrase?</p>
    <p>Lines 6-17: another limitation of counting virions under a microscope is that it does not distinguish physical from infectious particles. The same is true for qPCR. This is a really serious limitation, moreso even than cost, etc. In fact, I sort of wonder if this entire first paragraph is a little bit irrelevant to the question at hand, which is titrating infectious particles.</p>
    <p>Lines 19-22: Again, this isn’t quite true. They are certainly not easy to separate, but for instance with influenza there is some evidence that defective virions lacking genes sometimes have slightly different morphologies, etc—and can at least be partially separated by certain types of centrifugation. Again, like for lines 6-17, I sort of feel like the authors are spending a lot of time on not 100% accurate text that isn’t even really relevant to their main point and finding, which is titrating infectious particles.</p>
    <p>Lines 68-71: The same limitation can apply to endpoint dilution (e.g., TCID50) assays, as the actual cell being used for the experiment doesn’t always work for the endpoint dilution assay. For instance, people performing flu infections of human primary airway cells still titer the virus by TCID50 on MDCK cells as you can’t do a TCID50 in human primary airway cells.</p>
    <p>Reviewer #3: The manuscript by Cresta et al suggest a new platform for analyzing endpoint dilution assays of virus infection, which are currently based on mathematical approximations that introduce a bias into the outcome. While these errors are known and can be corrected, the calculations still show inconsistencies is specific cases.</p>
    <p>I think its in general a good idea to revisit such traditional assays, identify potential limitations and work on their improvement. The authors also provide their analysis as an open online tool, which is a nice example for the open science principles. The manuscript is well written but the real value of the tool needs to be worked out a bit more. While the presented tool overcomes some limitations, its use seems overstated as it does not solve all of the mentioned problems.</p>
    <p>1) There are many ways to quantify a virus sample and its important to consider what the assays measure. The authors aim at improving the estimation of an infection concentration meaning how many infections a virus sample could cause per unit volume. They compare plaque/focus forming assays with endpoint dilution methods. While the introduction gives a nice overview of these assays and highlights their limitations, in particular those of the plaque assay, it’s not a fair comparison. The plaque or focus assays use an overlay medium to restrict infection spread to only the neighboring cells. Infected cells and their infected neighbors will then after some time and following some form of coloring be visible as a plaque/focus. The ED assay (TCID50) typically does not use overlay medium and relies on immunostaining or CPE to score infection. Plaque and ED assay thus have usually different readouts, replication or infection. In the paper, the authors use hemagglutinating units to quantify the amount of released virus in their TCID50 assays. That is yet a different measure and might in include non-replicating particles.</p>
    <p>In my opinion is the proposed midSIN platform best suited to analyze traditional ED assays where infection is labelled with antibodies and can be analyzed with an automated reader. The manuscript (title, intro and discussion) is thus misleading in several places by saying that midSIN overcomes the limitations of a plaque assay.</p>
    <p>2) Another aspect that I think could be improved is the requirement of a threshold to score a well as positive. Can the analysis be performed using raw plate analyzer readings (fluorescence units per well)? That would be ideal and remove all personal bias from the analysis.</p>
    <p>**********</p>
    <p>
      <bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold>
    </p>
    <p>The <ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: Yes</p>
    <p>Reviewer #3: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: No</p>
    <p>Reviewer #3: No</p>
    <p>
      <underline>Figure Files:</underline>
    </p>
    <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email>figures@plos.org</email></underline>.</p>
    <p>
      <underline>Data Requirements:</underline>
    </p>
    <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" ext-link-type="uri">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
    <p>
      <underline>Reproducibility:</underline>
    </p>
    <p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link></p>
  </body>
</sub-article>
<sub-article article-type="author-comment" id="pcbi.1009480.r002">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009480.r002</article-id>
    <title-group>
      <article-title>Author response to Decision Letter 0</article-title>
    </title-group>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1009480" id="rel-obj002" related-article-type="editor-report"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="author-response-date">18 Aug 2021</named-content>
    </p>
    <supplementary-material id="pcbi.1009480.s001" position="float" content-type="local-data">
      <label>Attachment</label>
      <caption>
        <p>Submitted filename: <named-content content-type="submitted-filename">response.pdf</named-content></p>
      </caption>
      <media xlink:href="pcbi.1009480.s001.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pcbi.1009480.r003" specific-use="decision-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009480.r003</article-id>
    <title-group>
      <article-title>Decision Letter 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>De Boer</surname>
          <given-names>Rob J.</given-names>
        </name>
        <role>Deputy Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Regoes</surname>
          <given-names>Roland R</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 De Boer, Regoes</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>De Boer, Regoes</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1009480" id="rel-obj003" related-article-type="reviewed-article"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Submission Version</meta-name>
        <meta-value>1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">26 Sep 2021</named-content>
    </p>
    <p>Dear Dr. Beauchemin,</p>
    <p>We are pleased to inform you that your manuscript 'Time to revisit the endpoint dilution assay and to replace TCID50 as a measure of a virus sample's infection concentration' has been provisionally accepted for publication in PLOS Computational Biology.</p>
    <p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p>
    <p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
    <p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
    <p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
    <p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
    <p>Best regards,</p>
    <p>Roland R Regoes</p>
    <p>Associate Editor</p>
    <p>PLOS Computational Biology</p>
    <p>Rob De Boer</p>
    <p>Deputy Editor</p>
    <p>PLOS Computational Biology</p>
    <p>***********************************************************</p>
    <p>Reviewer's Responses to Questions</p>
    <p>
      <bold>Comments to the Authors:</bold>
    </p>
    <p>
      <bold>Please note here if the review is uploaded as an attachment.</bold>
    </p>
    <p>Reviewer #1: The authors have made a partial effort to comply with requests to shorten the manuscript. The manuscript has benefited greatly, but it is still excessively long. The length still partially obscures the justification for replacing the ID50 with the midSIN. The manuscript also retains the Spearman-Karber and Reed-Muench methods as a standard of comparison for the midSIN, and the bias in these methods is already known.</p>
    <p>I remain supportive of the development of web calculators to replace the Spearman-Karber and Reed-Muench methods, but the manuscript's presentation of the midSIN is unlikely to promote the replacement much, if at all.</p>
    <p>Reviewer #2: The paper is much improved, and I support is publication.</p>
    <p>Reviewer #3: The authors have addressed my comments and, together with the other revisions, well improved the readability of the manuscript. I realised that my comments were not always as precise as I wished, but the authors well grasped their point and responded adequately. midSin is an easy to use tool that I will see to include in my groups activities.</p>
    <p>**********</p>
    <p>
      <bold>Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?</bold>
    </p>
    <p>The <ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/materials-and-software-sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.</p>
    <p>Reviewer #1: Yes</p>
    <p>Reviewer #2: Yes</p>
    <p>Reviewer #3: Yes</p>
    <p>**********</p>
    <p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
    <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
    <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p>
    <p>Reviewer #1: No</p>
    <p>Reviewer #2: No</p>
    <p>Reviewer #3: No</p>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="pcbi.1009480.r004" specific-use="acceptance-letter">
  <front-stub>
    <article-id pub-id-type="doi">10.1371/journal.pcbi.1009480.r004</article-id>
    <title-group>
      <article-title>Acceptance letter</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>De Boer</surname>
          <given-names>Rob J.</given-names>
        </name>
        <role>Deputy Editor</role>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Regoes</surname>
          <given-names>Roland R</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <permissions>
      <copyright-statement>© 2021 De Boer, Regoes</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>De Boer, Regoes</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <related-article ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1009480" id="rel-obj004" related-article-type="reviewed-article"/>
  </front-stub>
  <body>
    <p>
      <named-content content-type="letter-date">13 Oct 2021</named-content>
    </p>
    <p>PCOMPBIOL-D-21-00213R1 </p>
    <p>Time to revisit the endpoint dilution assay and to replace TCID₅₀ as a measure of a virus sample's infection concentration</p>
    <p>Dear Dr Beauchemin,</p>
    <p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
    <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
    <p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
    <p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
    <p>With kind regards,</p>
    <p>Andrea Szabo</p>
    <p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email>ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link xlink:href="http://ploscompbiol.org" ext-link-type="uri">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
  </body>
</sub-article>
